Intellicheck (IDN) 10-K1 Apr 242023 FY Annual reportFinancial data

Company Profile

Cover

Cover - USD ($)	12 Months Ended
Cover - USD ($)	Dec. 31, 2023	Apr. 01, 2024	Jun. 30, 2023
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2023
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-15465
Entity Registrant Name	Intellicheck, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-3234779
Entity Address, Address Line One	200 Broadhollow Road
Entity Address, Address Line Two	Suite 207
Entity Address, City or Town	Melville
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11747
City Area Code	(516)
Local Phone Number	992-1900
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	IDN
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction	false
Entity Shell Company	false
Entity Public Float			$ 38,160,104
Entity Common Stock, Shares Outstanding		19,404,561
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE: Portions of Intellicheck, Inc.’s definitive Proxy Statement for its 2024 Annual Meeting of Shareholders to be filed with the U.S. Securities and Exchange Commission pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended, are incorporated by reference into Part III of this Annual Report on Form 10-K.
Entity Central Index Key	0001040896
Document Fiscal Period Focus	FY
Amendment Flag	false
Document Fiscal Year Focus	2023

Audit Information

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2023
Audit Information [Abstract]
Auditor Name	FORVIS, LLP
Auditor Location	Tysons, VA
Auditor Firm ID	686

BALANCE SHEETS

BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 3,980	$ 5,196
Short-term investments	5,000	4,880
Accounts receivable, net of allowance of $69 and $20 as of December 31, 2023, and 2022, respectively	4,703	2,637
Other current assets	692	608
Total current assets	14,375	13,321
PROPERTY AND EQUIPMENT, NET	666	749
GOODWILL	8,102	8,102
INTANGIBLE ASSETS, NET	575	273
OTHER ASSETS	90	8
Total assets	23,808	22,453
CURRENT LIABILITIES:
Accounts payable	884	358
Accrued expenses	3,245	3,156
Income taxes payable	0	90
Equity awards liability	4	54
Liability for shares withheld	190	221
Deferred revenue, current portion	2,209	906
Total current liabilities	6,532	4,785
OTHER LIABILITIES
Deferred revenue, long-term portion	0	1
Total liabilities	6,532	4,786
COMMITMENTS AND CONTINGENCIES (Note 10)
STOCKHOLDERS’ EQUITY:
Preferred stock – $0.01 par value; 30,000 shares authorized; Series A convertible preferred stock, zero shares issued and outstanding as of December 31, 2023 and 2022, respectively	0	0
Common stock – $.001 par value; 40,000,000 shares authorized; 19,354,335 and 18,957,366 shares issued and outstanding as of December 31, 2023 and 2022, respectively	19	19
Additional paid-in capital	150,822	149,233
Accumulated deficit	(133,565)	(131,585)
Total stockholders’ equity	17,276	17,667
Total liabilities and stockholders’ equity	$ 23,808	$ 22,453

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 69	$ 20
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	30,000	30,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	40,000,000	40,000,000
Common stock, shares issued (in shares)	19,354,335	18,957,366
Common stock, shares outstanding (in shares)	19,354,335	18,957,366

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
REVENUES	$ 18,906	$ 15,966
COST OF REVENUES	(1,375)	(1,275)
Gross profit	17,531	14,691
OPERATING EXPENSES
Selling, general and administrative	15,127	12,707
Research and development	4,680	6,014
Total operating expenses	19,807	18,721
Loss from operations	(2,276)	(4,030)
OTHER INCOME (EXPENSE)
Interest and other income (expense)	234	(5)
Total other income (expense)	234	(5)
Net loss before provision (benefit) for income taxes	(2,042)	(4,035)
Provision (Benefit) for income taxes	(62)	124
Net loss	$ (1,980)	$ (4,159)
Loss per common share -
Basic (in dollars per share)	$ (0.10)	$ (0.22)
Diluted (in dollars per share)	$ (0.10)	$ (0.22)
Weighted average common shares used in computing per share amounts -
Basic (in shares)	19,243,179	18,838,971
Diluted (in shares)	19,243,179	18,838,971

STATEMENTS OF STOCKHOLDERS_ EQU

STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		18,660,369
Beginning balance at Dec. 31, 2021	$ 19,048	$ 19	$ 146,455	$ (127,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,544)
Ending balance at Mar. 31, 2022	18,333
Beginning balance (in shares) at Dec. 31, 2021		18,660,369
Beginning balance at Dec. 31, 2021	19,048	$ 19	146,455	(127,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,714)
Ending balance at Jun. 30, 2022	17,683
Beginning balance (in shares) at Dec. 31, 2021		18,660,369
Beginning balance at Dec. 31, 2021	19,048	$ 19	146,455	(127,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,512)
Ending balance at Sep. 30, 2022	17,581
Beginning balance (in shares) at Dec. 31, 2021		18,660,369
Beginning balance at Dec. 31, 2021	19,048	$ 19	146,455	(127,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,778		2,778
Issuance of shares for vested restricted stock grants (in shares)		296,997
Net loss	(4,159)			(4,159)
Ending balance (in shares) at Dec. 31, 2022		18,957,366
Ending balance at Dec. 31, 2022	17,667	$ 19	149,233	(131,585)
Beginning balance at Mar. 31, 2022	18,333
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,170)
Ending balance at Jun. 30, 2022	17,683
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(798)
Ending balance at Sep. 30, 2022	17,581
Beginning balance at Dec. 31, 2022	17,667	$ 19	149,233	(131,585)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,387)
Ending balance at Mar. 31, 2023	16,922
Beginning balance (in shares) at Dec. 31, 2022		18,957,366
Beginning balance at Dec. 31, 2022	17,667	$ 19	149,233	(131,585)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,240)
Ending balance at Jun. 30, 2023	16,353
Beginning balance (in shares) at Dec. 31, 2022		18,957,366
Beginning balance at Dec. 31, 2022	17,667	$ 19	149,233	(131,585)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,964)
Ending balance at Sep. 30, 2023	16,007
Beginning balance (in shares) at Dec. 31, 2022		18,957,366
Beginning balance at Dec. 31, 2022	17,667	$ 19	149,233	(131,585)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,646		1,646
Issuance of common stock for vested restricted stock units and earned performance stock units (in shares)		421,689
Shares forfeited in exchange for withholding taxes (in shares)		(24,720)
Shares forfeited in exchange for withholding taxes	(57)		(57)
Net loss	(1,980)			(1,980)
Ending balance (in shares) at Dec. 31, 2023		19,354,335
Ending balance at Dec. 31, 2023	17,276	$ 19	$ 150,822	$ (133,565)
Beginning balance at Mar. 31, 2023	16,922
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(853)
Ending balance at Jun. 30, 2023	16,353
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(724)
Ending balance at Sep. 30, 2023	$ 16,007

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,980)	$ (4,159)
Adjustments to reconcile Net loss to net cash (used in) operating activities:
Depreciation and amortization	282	285
Stock-based compensation	1,596	2,455
Allowance for credit losses	49	17
Change in accrued interest and accretion of discount on short-term investments	(206)	0
Changes in assets and liabilities:
(Increase) in accounts receivable	(2,115)	(462)
(Increase) decrease in other current assets	(84)	34
(Increase) in other assets	(82)	0
Increase (decrease) in accounts payable and accrued expenses	616	(260)
Increase (decrease) in deferred revenue	1,302	(367)
(Decrease) in other current liabilities	(25)	(1,023)
Net cash (used in) operating activities	(647)	(3,480)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(93)	(192)
Proceeds from maturity of short-term investments	5,000	0
Purchases of short-term investments	(4,914)	(4,880)
Software development and other costs	(407)	0
Net cash (used in) investing activities	(414)	(5,072)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from insurance financing arrangement	49	319
Withholding taxes paid on RSU vesting	(57)	0
Repayment of insurance financing arrangement	(147)	(222)
Net cash (used in) provided by financing activities	(155)	97
Net (decrease) in cash	(1,216)	(8,455)
CASH, beginning of year	5,196	13,651
CASH, end of year	3,980	5,196
Supplemental disclosures of cash flow information:
Cash paid for interest	2	5
Cash paid for income taxes	$ 80	$ 31

NATURE OF BUSINESS

NATURE OF BUSINESS	12 Months Ended
NATURE OF BUSINESS	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF BUSINESS	NATURE OF BUSINESS Business Intellicheck, Inc. (the “Company” or “Intellicheck”) is a prominent technology company that is engaged in developing, integrating and marketing identity verification solutions to address challenges that include commercial retail and banking fraud prevention. Intellicheck’s products include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices. Intellicheck continues to develop and release innovative products based upon its rich patent portfolio consisting of ten ( 10) U.S. and one Canadian patents. Liquidity For the year ended December 31, 2023, the Company incurred a net loss of $(1,980) and had net cash used in operating activities of $(647). As of December 31, 2023, the Company had cash and cash equivalents of $3,980, short term investments of $5,000, working capital (defined as current assets minus current liabilities) of $7,843 and an accumulated deficit of $133,565. Based on the Company’s business plan and cash resources, Intellicheck expects its existing and future resources and revenues generated from operations to satisfy its working capital requirements for at least the next 12 months from the date of filing.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2023
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Use of Estimates The preparation of the Company’s financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the Company’s financial statements and accompanying notes. Significant estimates and assumptions that affect amounts reported in the financial statements include impairment consideration and valuation of goodwill and intangible assets, deferred tax valuation allowances, allowance for doubtful accounts, revenue recognition (including breakage revenue) and the fair value of stock options granted under the Company’s Equity compensation plan. Due to the inherent uncertainties involved in making estimates, actual results reported in future periods may be different from those estimates. ASC Topic 718, " Compensation - Stock Compensation ", establishes fair value as the measurement objective in accounting for equity payment arrangements and requires all companies to apply a fair-value based measurement method in accounting for all equity payment transactions with employees. The Company determined the fair value of these awards utilizing a Black-Scholes option pricing model. Allowance for Credit Losses Effective January 1, 2023 Intellicheck applied the new standard ASU 2016-13, codified as ASC 326. This impacts how the allowance for doubtful accounts is calculated. Prior to ASC-326, Intellicheck would not recognize bad debt expense until the loss from customer non-payment was probable of occurring. Under the new model, Intellicheck’s allowance for doubtful accounts reflects the Company’s estimate of all expected future credit losses from its current customer balances. Under the new guidance, the Company has applied a loss rate method which takes historical data as the basis for calculating the allowance amount, along with accounting for other factors like current and forecasted market conditions, and potential future impacts to the industry. In estimating whether accounts receivable will be collected, the Company performs evaluations of customers and continuously monitors collections and payments and estimates an allowance for credit losses based on collections experience to date and any specific collection issues that have been identified. The allowance for credit losses is recorded in the period in which revenue is recorded or when collection risk is identified. Cash and Cash Equivalents We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents. Our cash and cash equivalents consist primarily of both cash on deposits with banks, which are maintained with major financial institutions in the United States, and money market funds. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000, however amounts may exceed FDIC insured limits. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash bank accounts. Short-term investments Short-term investments include investments in U.S. treasury notes. Debt investments with original maturities at the date of purchase greater than approximately three months but less than a year are classified as short-term investments, as they represent the investment of cash available for current operations. All short-term investments that the Company holds are classified as "held-to-maturity" as the Company has the intent and ability to hold these investments until maturity. See Note 3 for more detail and a breakdown of the Company's short-term investments. Long-Lived Assets and Impairment of Long-Lived Assets The Company’s long-lived assets include property and equipment, goodwill, and intangible assets. The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable in accordance with Accounting Standards Codification (“ASC”) 350 (“ Intangibles – Goodwill and Other ”) and ASC 360 (“ Property, Plant and Equipment ”). To determine recoverability of its long-lived assets, the Company evaluates the probability that future undiscounted net cash flows, without interest charges, will be less than the carrying amount of the assets. Impairment is measured at fair value. Property and Equipment Property and equipment are recorded at cost and are depreciated over their estimated useful lives ranging from three Goodwill Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC 350, the Company tests goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assesses qualitative factors to determine whether it is necessary to perform step one of the quantitative goodwill impairment test. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price. The Company performed its annual impairment test of goodwill in the fourth quarter for the years ended December 31, 2023 and December 31, 2022, more detail about this is referenced in Note 5. For the years ended December 31, 2023 and 2022, the Company determined no impairment charge was required. Intangible Assets Intangible assets include patents, copyrights, developed technology and capitalized software development costs. The Company amortizes these assets on a straight-line basis over their estimated useful lives, as it represents the pattern of economic benefits consumed. There were no impairment charges recognized for the years ended December 31, 2023 and 2022. See Note 5. We capitalize internal-use software costs which includes costs incurred in connection with the development of new software solutions and enhancements to existing software solutions that are expected to result in increased functionality. The costs incurred in the preliminary stages of development are expensed as incurred. Once the software has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is complete and available for its intended use. We evaluate the useful lives of these assets and test for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. There were no impairments of capitalized software development costs for the years ended December 31, 2023 and 2022. Revenue Recognition and Deferred Revenue General Most license fees and services revenue are generated from a combination of fixed-price and per-scan contracts. Under the per-scan revenue model, customers are charged a fee each time the customer scans an identity document, such as a driver’s license, with the Company’s software. Under the fixed-price revenue model customers are charged a fixed monthly fee either per device or physical business location to access the Company’s software. Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration expected to be received in exchange for those goods or services. The Company measures revenue based on the consideration specified in a customer arrangement, and revenue is recognized when the performance obligations in an arrangement are satisfied. A performance obligation is a promise in a contract to transfer a distinct service to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when, or as, the customer receives the benefit of the performance obligation. Customers typically receive the benefit of the Company’s services as they are performed. The Company's performance obligations are satisfied over time, and as a result, we may follow the right to invoice practical expedient meaning we recognize revenue monthly as invoiced based on our contract terms. The Company has an additional revenue model where customers purchase a predetermined number of transactions for the term of the contract. Customers are charged a fixed monthly fee for a set number of scans (fixed consideration), with any overages charged on a per scan basis (variable consideration). The Company estimates the amount of unused transactions at the end of each contract period and recognizes a portion of that revenue as breakage revenue each reporting period. If the Company expects the customer to use all transactions in the specified service period, the Company will recognize the transaction price as revenue in the specified service period as the promised units of service are transferred to the customer. Alternatively, if the Company expects that the customer cannot or will not use all transactions in the specified service period (referred to as “breakage”), the Company will recognize the estimated breakage amount as revenue ratably over the service period in proportion to the revenue that the Company will recognize for actual transactions used by the customer in the service period. The company does not estimate the variable consideration at any point; rather we calculate and recognize the variable portion at the end of the contract term since these contracts are considered monthly due to the termination clauses included within them. The fixed and variable performance obligations are recognized monthly based on the contract terms. Invoicing is based on schedules established in customer contracts. Payment terms are generally established from 30 to 60 days from the invoice date. Accordingly, the Company has determined that its contracts do not include a significant financing component. Product returns are estimated and recorded as a reduction to revenue, however, such amounts have been immaterial. The Company has not capitalized any costs to obtain a contract as the period of amortization for these associated costs would have been recognized over a period that is one year or less and the Company elected the practical expedient to expense those costs as incurred. Nature of goods and services The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each: Software as a Service (SaaS) Software as a service (SaaS) for hosted subscription services requires the Company to provide a stand-ready obligation and allows customers to access a set of data for a predetermined period of time. As the customer obtains access at a point in time but continues to have access for the remainder of the subscription period, the customer is considered to simultaneously receive and consume the benefits provided by the entity’s performance as the entity performs. Accordingly, the revenue should be recognized over time, under the fixed pricing model, based on the usage of the hosted subscription services, which can vary from month to month. Under the per-scan revenue model, the customer requires access to the Company's hosted subscription service but revenue is recognized over time as the customer scans an identity document. Equipment Revenue Revenue from the sale of equipment is recognized at a point in time. The point in time that the revenue is recognized is when the customer has control of the equipment which is when the customer receives the benefit and the Company’s performance obligation has been satisfied. Depending on the contract terms, that could either be at the time the equipment is shipped or at the time the equipment is received. Other Revenue Other Revenues, which historically have not been material, consist primarily of revenues from other subscription and support services, and extended warranties. The Company’s revenues from other subscription and support services includes jurisdictional updates to certain commercial customers and support services particularly to its Defense ID® customers. These subscriptions require continuing service or post contractual customer support and performance. As the customer obtains access at a point in time but continues to have access for the remainder of the subscription period, the customer is considered to simultaneously receive and consume the benefits provided by the Company’s performance as the Company performs. Accordingly, the revenue is recognized over time based on usage, which can vary from month to month. The revenue is typically based on a formula such as number of locations in a given month multiplied by a fee per location. Extended warranty revenues are generated when a warranty is provided to the customer separately of other performance obligations when the equipment is sold. As the customer obtains access at a point in time and continues to have access for the remainder of the warranty term, the customer is considered to simultaneously receive and consume the benefits provided by the Company’s performance as the Company performs. The related revenue is recognized ratably over the specified term of the warranty period. The extended warranty is separate from the Company’s standard warranty that it receives from its vendor, which is typically one year. Disaggregation of revenue In the following tables, revenue is disaggregated by product and service and the timing of revenue recognition. The table also includes a reconciliation of the disaggregated revenue. For the Years Ended December 31, 2023 2022 Products and services Software as a Service (SaaS) $ 18,595 $ 15,728 Other 146 26 Equipment 165 212 $ 18,906 $ 15,966 Timing of revenue recognition Products transferred at a point in time $ 311 $ 238 Services transferred over time 18,595 15,728 $ 18,906 $ 15,966 Contract balances The current portion of deferred revenue at December 31, 2023 and December 31, 2022 was $2,209 and $906, respectively, and primarily consists of revenue that is recognized over time for software license contracts and hosted subscription services. The changes in these balances are related to the satisfaction or partial satisfaction of these contracts. The entire December 31, 2022, current deferred revenue balance was recognized as revenue in the year ended December 31, 2023. The noncurrent deferred revenue balances were $0 and $1 as of December 31, 2023, and December 31, 2022, respectively. Transaction price allocated to the remaining performance obligations The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the reporting period: 2024 2025 2026 Total Software as a Service (SaaS) $ 2,201 $ — $ — $ 2,201 Other 8 — — 8 $ 2,209 $ — $ — $ 2,209 All consideration from contracts with customers is included in the amounts presented above. Advertising Costs. Advertising costs, which are charged to expense as incurred and recorded as selling, general and administrative expenses in our statements of operations, were $536 and $683 for the years ended December 31, 2023 and 2022, respectively. Shipping Costs The Company’s shipping and handling costs related to sales are included in cost of revenues for all periods presented. All other shipping and handling costs are included as a component of selling, general and administrative expenses within the Statements of Operations. Loss Contingencies and Legal Costs The Company accrues loss contingencies that are believed to be probable and can be reasonably estimated. As events evolve during the administration and litigation process and additional information becomes known, the Company reassesses its estimates related to loss contingencies. Legal costs are expensed in the period in which the costs are incurred. Sales Taxes Sales and other taxes collected from customers and remitted to governmental authorities are presented on a net basis and thus excluded from revenues. Income Taxes The Company accounts for income taxes in accordance with ASC 740, “ Income Taxes .” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss carryforwards. Deferred tax assets and liabilities are measured using expected tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Deferred tax assets are recognized subject to management’s judgment that realization is more likely than not. The Company has recorded a full valuation allowance for its net deferred tax assets as of December 31, 2023 and 2022, due to the uncertainty of the realizability of those assets. See Note 8. Fair Value of Financial Instruments The Company adheres to the provisions of ASC 820, “ Fair Value Measurement ” which requires the Company to calculate the fair value of financial instruments and include this additional information in the notes to financial statements when the fair value of those financial instruments is different than the book value. The Company’s financial instruments include cash and cash equivalents, short-term investments, accounts receivable, other current assets, accounts payable and accrued expenses. At December 31, 2023 and 2022, the carrying value of the Company’s financial instruments approximated fair value, due to their short-term nature. Financial Accounting Standards Board (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: •Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. The Company's Level 1 assets consisted primarily of cash and cash equivalents as well as short-term investments totaling approximately $8,980 and $10,076 as of December 31, 2023 and 2022, respectively. •Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies. The Company had $4 and $54 of Level 2 liabilities as of December 31, 2023 and December 31, 2022 respectively, for the liability-classified stock options. The fair value of these awards were determined by utilizing a Black-Scholes option pricing model. •Level 3—Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when the fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The Company had no Level 3 assets or liabilities as of December 31, 2023 and December 31, 2022. There were no transfers into or out of Level 3 measurements in 2023 and 2022. Business Concentration and Credit Risk Financial instruments, which subject the Company to concentrations of credit risk, consist primarily of cash. The Company maintains cash at two financial institutions. The Company performs periodic evaluations of the relative credit standing of these institutions. The Company’s sales are principally made to large retail customers, financial institutions concentrated in the United States and to U.S. government entities. The Company performs ongoing credit evaluations, generally does not require collateral, and establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of customers, historical trends, and other market and economic information. During the year ended December 31, 2023, the Company made sales to three customers that accounted for approximately 47% of revenue, 21%, 14% and 12%, respectively. The revenue was associated with commercial identity sales customers. These three customers represented 66% of the Company’s December 31, 2023 accounts receivable balance. These three customers accounted for approximately 37%, 6%, and 23% , respectively, of the Company's accounts receivable balance at December 31, 2023. During the year ended December 31, 2022, the Company had three customers that accounted for 52% of revenue; 22%, 17% and 13%, respectively and those same three customers, including one other customer together accounted for 63%; 37%, 11%, 1% and 14%, respectively, of its December 31, 2022 accounts receivable balance. As of December 31, 2023, the Company had four suppliers to produce its input devices. The Company has modified its software to operate in Windows-based systems and can integrate with different hardware platforms that are readily available in the marketplace. The Company does not maintain a manufacturing facility of its own and is not dependent on maintaining its production relationships due to the flexibility of its software to run on multiple existing platforms. Net Loss Per Share Basic net loss per share is computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted average number of shares of common stock and potentially dilutive common stock equivalents outstanding during the period. The dilutive effect of these common stock equivalents comprising of outstanding options, warrants and restricted stock is reflected in diluted earnings per share by application of the treasury stock method. The calculation of diluted net loss per share excludes all anti-dilutive shares. In a period of net loss, all common stock equivalents are considered anti-dilutive. Years Ended 2023 2022 Numerator: Net Loss $ (1,980) $ (4,159) Denominator: Weighted average common shares – Basic 19,243,179 18,838,971 Weighted average common shares - Diluted 19,243,179 18,838,971 Net Loss per share – Basic $ (0.10) $ (0.22) Diluted $ (0.10) $ (0.22) The following table summarizes the common stock equivalents excluded from the 2023 and 2022 loss per diluted share because their effect would be anti-dilutive: 2023 2022 Stock options 1,152,714 1,120,244 Restricted stock 60,500 214,892 Performance stock units — 177,688 Total 1,213,214 1,512,824 Stock-based Compensation The Company accounts for the issuance of equity awards to employees in accordance ASC 718 (“ Compensation - Stock Compensation ) and ASC 505 (“ Equity ”), which requires that the cost resulting from all equity payment transactions be recognized in the financial statements. This pronouncement establishes fair value as the measurement objective in accounting for equity payment arrangements and requires all companies to apply a fair value-based measurement method in accounting for all equity payment transactions with employees and directors. All stock-based compensation expenses are included in operating expenses. The Company recognizes compensation expense related to equity grants on a straight-line basis over the requisite service period. See Note 9. Segment Information The Company adheres to the provisions of ASC 280 (“ Segment Reporting ”), which establishes standards for the way public business enterprises report information about operating segments in annual financial statements and requires that those enterprises report selected information about operating segments in financial statements issued to shareholders. The Company’s Chief Operating Decision Maker, its Chief Executive Officer (“CEO”), reviews the financial information presented for purposes of allocating resources and evaluating its financial performance. Accordingly, the Company has determined that it operates in a single reportable segment. All of the Company’s long-lived assets are located in the United States. Since the Company operates in one operating segment, all required financial segment information can be found in the financial statements. Research and Development Research and development expenses are expensed as incurred and consist primarily of employee-related expenses (such as salaries, taxes, benefits and stock-based compensation), allocated overhead costs and outside services costs related to the development and improvement of the Company's SaaS applications. Recent Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13") to measure credit losses on financial instruments, including trade receivables. The guidance eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate can now reflect an entity’s current estimate of all future expected credit losses. Under the previous guidance, an entity only considered past events and current conditions. The Company concluded that the adoption of this standard, on January 1, 2023, did not have a material impact on its financial statements because of the short-term nature of its outstanding accounts receivable and there have been no significant forward-looking economic conditions identified by the Company that would impact its short-term investments. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances reporting requirements under Topic 280. The enhanced disclosure requirements include: title and position of the Chief Operating Decision Maker (CODM), significant segment expenses provided to the CODM, extending certain annual disclosures to interim periods, clarifying single reportable segment entities must apply ASC 280 in its entirety, and permitting more than one measure of segment profit or loss to be reported under certain circumstances. This change is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. This change will apply retrospectively to all periods presented. The Company is currently evaluating the impact of this ASU on its financial statements. In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740), which establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing requirements. The new guidance requires consistent categorization and greater disaggregation of information in the rate reconciliation, as well as further disaggregation of income taxes paid. This change is effective for annual periods beginning after December 15, 2024. This change will apply on a prospective basis to annual financial statements for periods beginning after the effective date. However, retrospective application in all prior periods presented is permitted. The Company is currently evaluating the impact of this ASU on its financial statements. Revision of Previously Reported Financial Statements In connection with the preparation of its financial statements for the year ended December 31, 2023, the Company determined that it had a historical state sales and use tax liability related to prior periods that was not reflected in previously issued financial statements. See Note 12 for further details. Reclassification of Prior Year Presentation Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on net earnings. An adjustment has been made to the Condensed Statements of Cash Flows to reclassify the allowance for credit losses. This change in classification does not affect previously reported cash flows from operating activities in the Condensed Statements of Cash Flows.

CASH EQUIVALENTS AND SHORT-TERM

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS	12 Months Ended
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS	CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS Short-term investments include investments in U.S. Treasury notes. Short-term investments with original maturities of approximately three months or less from the date of purchase are classified within cash and cash equivalents. Debt investments with original maturities at the date of purchase greater than approximately three months but less than one year are classified as short-term investments, as they represent the investment of cash available for current operations. All short-term investments that the company holds are classified as "held-to-maturity". The Company has accounted for and disclosed the purchase of its short-term investments in accordance with ASC 320 ("I nvestments - Debt Securities "). The following table summarizes the fair value of cash and cash equivalents, and short-term investments as well as any gross unrealized holding gains and losses as of December 31, 2023. Due to the nature of these assets and the short-term nature of the U.S. treasury notes being held to maturity, both these cash and cash equivalents and short-term investments fall under the Level 1 fair value hierarchy as referenced in Note 2. As of December 31, 2023 Amortized cost Gross unrealized holding gains Gross unrealized holding losses Estimated fair value Cash and cash equivalents $ 3,980 $ — $ — $ 3,980 U.S. treasury notes (1) 5,000 — — 5,000 Total cash, cash equivalents and short-term investments $ 8,980 $ — $ — $ 8,980 As of December 31, 2022 Amortized cost Gross unrealized holding gains Gross unrealized holding losses Estimated fair value Cash and cash equivalents $ 5,196 $ — $ — $ 5,196 U.S. treasury notes (2) 4,880 3 (15) 4,868 Total cash, cash equivalents and short-term investments $ 10,076 $ 3 $ (15) $ 10,064 (1) These U.S. treasury notes are classified as "held-to-maturity" as they were purchased in August 2023 and will mature in January 2024. Any coupon payments or accretion of discounts from these short-term investments fall under "Interest and other income (expense)" in the Company's Statement of Operations. (2) These U.S. treasury notes were classified as "held-to-maturity" as they were purchased in December 2022 and matured in July 2023. The Company did not hold any securities that were in an unrealized loss position for more than 12 months as of December 31, 2023 and 2022. The Company recognized $206 and zero in realized gains on short-term investments that matured within the years ended December 31, 2023 and 2022, respectively.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
PROPERTY AND EQUIPMENT	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	PROPERTY AND EQUIPMENT Property and equipment are comprised of the following as of December 31, 2023 and 2022: 2023 2022 Computer equipment and software $ 1,886 $ 1,796 Furniture and fixtures 139 139 Office equipment 618 614 2,643 2,549 Less – Accumulated depreciation (1,977) (1,800) $ 666 $ 749 Depreciation expense for the years ended December 31, 2023 and 2022 amounted to $177 and $180 respectively. Depreciation expense is included in the Statement of Operations within the selling, general and administrative line item.

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	12 Months Ended
GOODWILL AND INTANGIBLE ASSETS	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS Identifiable intangible assets The following tables set forth the components of intangible assets as of December 31, 2023 and 2022: Estimated As of December 31, 2023 Adjusted Accumulated Net Patents and copyrights 2-17 years $ 375 $ (300) $ 75 Developed technology 5 years 400 (307) 93 Software development - 407 — 407 $ 1,182 $ (607) $ 575 Estimated As of December 31, 2022 Adjusted Accumulated Net Patents and copyrights 2-17 years $ 375 $ (275) $ 100 Developed technology 5 years 400 (227) 173 $ 775 $ (502) $ 273 The Company has capitalized $407 in software development costs to date. The projects are still in development and not yet ready for their intended use and therefore no estimated useful life has been determined and these costs are not being amortized as of December 31, 2023. The following summarizes amortization of acquisition related intangible assets included in the Statement of Operations: Years Ended December 31, 2023 2022 Cost of revenues $ 95 $ 95 Selling, general and administrative 10 10 $ 105 $ 105 The Company expects amortization expense for the next five succeeding years will be as follows: 2024 $ 105 2025 39 2026 20 2027 4 2028 — $ 168 These amounts are subject to change based upon the review of recoverability and useful lives that are performed at least annually. Goodwill Goodwill represents the excess of purchase price over the fair value of the assets acquired in businesses combinations. Under ASC 350, purchased goodwill is not amortized, but rather is tested for impairment. The Company’s goodwill balance was $8,102 as of December 31, 2023 and 2022. This goodwill resulted from the acquisitions of Mobilisa, Inc. and Positive Access Corporation. For the years ended December 31, 2023 and 2022, the Company performed its annual impairment test of goodwill in the fourth quarter. Under authoritative guidance, the Company can use industry and Company specific qualitative factors to determine whether it is more likely than not that impairment exists before performing step one of the quantitative goodwill impairment test. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price. The Company performed the first step of the goodwill impairment test to identify potential impairment by comparing the fair value of the Company to its carrying amount, including goodwill. The fair value was determined using the weighting of certain valuation techniques, including both income and market approaches which include a discounted cash flow analysis, an analysis of similar public company financial information, and an analysis of market transactions. Although the Company believes that the factors considered in the impairment analysis are reasonable, changes in any one of the assumptions used could have produced a different result which may have led to an impairment charge. For the years ended December 31, 2023 and 2022, the Company determined that the fair value of the Company was greater than its carrying amount and therefore the second step of the goodwill impairment test was not required.

DEBT

DEBT	12 Months Ended
DEBT	Dec. 31, 2023
Debt Disclosure [Abstract]
DEBT	DEBT Revolving Line of Credit On February 6, 2019, the Company entered into a revolving credit facility with Citi Personal Wealth Management that allows for borrowings up to the lesser of (i) $2,000 or (ii) the collateralized balance in the Company’s existing fixed income investment account with Citi Personal Wealth Management subject to certain limitations. The facility bears interest at a rate consistent of Citi Personal Wealth Management’s Base Rate (8.50% and 7.50% at December 31, 2023 and December 31, 2022) minus 2%. Interest is payable monthly and as of December 31, 2023 and 2022, there were no amounts outstanding under this facility and unused availability under this facility was $2,000. The Company is not subject to any financial covenants related to this revolving line of credit. This line will remain open as long as the Company maintains depository relationship with the financial institution. Insurance Financing Arrangement In February 2023, the Company entered into a financing arrangement related to insurance premiums totaling $49 with an interest rate of 9.47%. The monthly loan payments of $5 were paid to financing company over a period of 11 months. As of December 31, 2023, the Company had no remaining commitments related to this financing arrangement.The Company was not subject to any financial covenants related to this insurance financing arrangement. On June 17, 2022, the Company entered a financing arrangement related to insurance premiums totaling $319 with an interest rate of 4.05%. The monthly loan payments of $32 were paid to a separate financing company for a total of 10 months. As of December 31, 2023, the Company had no remaining commitments related to this financing arrangement.

ACCRUED EXPENSES

ACCRUED EXPENSES	12 Months Ended
ACCRUED EXPENSES	Dec. 31, 2023
Payables and Accruals [Abstract]
ACCRUED EXPENSES	ACCRUED EXPENSES Accrued expenses are comprised of the following as of December 31, 2023 and 2022: 2023 2022 (As Adjusted) Professional fees $ 1 $ 259 Payroll and related 1,159 1,040 Incentive bonuses 824 846 Sales tax accrual 1,064 837 Other 197 174 $ 3,245 $ 3,156

INCOME TAXES

INCOME TAXES	12 Months Ended
INCOME TAXES	Dec. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company’s deferred tax assets and liabilities are measured using the enacted tax rates that the Company believes will apply in the years in which temporary differences are expected to be recovered or paid. The Company is subject to federal and state income taxes as a Subchapter C corporation. The Company’s deferred tax assets are primarily the result of net operating losses (or NOLs). The Company has recorded a valuation allowance against its net deferred tax assets at December 31, 2023 as it is more likely than not that not all of the deferred tax assets will be realized. The valuation is based on management’s assessment that it is more likely than not the NOL carryforwards may not be realized in the foreseeable future due to objective negative evidence that the Company would not generate sufficient taxable income to realize the deferred tax assets. The provision for income taxes as of December 31, 2023 and 2022 consists of the following: 2023 2022 Current: Federal $ (12) $ — State (50) 124 Total current tax (benefit) expense (62) 124 Deferred: Federal — — State — — Total deferred tax (benefits) expense — — (Benefit) Provision for income taxes $ (62) $ 124 A reconciliation of the statutory U.S. Federal rate to the Company’s effective tax rate as of December 31, 2023 and 2022 is as follows: 2023 2022 (As Adjusted) Federal income tax benefit at statutory rate 21.00 % 21.00 % State income taxes, net of federal benefit 0.25 (2.20) Other permanent items (0.30) (0.04) Stock-based compensation (9.94) (1.99) Lobbying expense (1.95) (0.92) Research and development tax credits (9.66) 9.92 Cumulative deferred adjustments (31.39) 26.14 Rate change (2.22) (18.06) Change in valuation allowance 36.20 (36.30) Other 1.07 (0.66) Effective income tax (benefit) expense rate 3.06 % (3.11) % Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets for federal and state income taxes as of December 31, 2023 and 2022 are as follows: 2023 2022 (As Adjusted) Deferred tax assets: Net operating loss carryforwards $ 5,625 $ 4,889 Payroll related accruals 256 333 Stock-based compensation 88 612 Intangible assets 90 89 Sec. 174 Capitalized costs 468 1,237 Sales tax accrual 245 197 Other 17 5 Depreciation 50 18 Research and development tax credits 708 906 Total deferred tax assets 7,547 8,286 Net deferred tax assets 7,547 8,286 Less: Valuation allowance (7,547) (8,286) Deferred tax assets, net of allowance $ — $ — The Company’s available NOL at December 31, 2023 was approximately $26.3 million, of which $10.9 million expires between 2035 and 2037. In accordance with the Tax Cuts and Jobs Act of 2017 (the "Tax Act"), U.S. NOLs arising in a tax year ending after 2017 in the amount of $15.4 million will not expire, but are subject to 80% limitation on utilization. In addition to the NOLs, the Company has approximately $708 thousand of research and development credits. The Company files numerous tax returns in various jurisdictions. The Company is not currently under examination by any taxing authority, nor has the Company signed any waiver of the statute of limitations with any taxing authority. The Company remains open to examination by major taxing jurisdictions from 2015 to date. ASC 740 requires evaluation of uncertain tax positions and as of December 31, 2023, the Company has no material uncertain tax positions. There were no tax interest or penalties recorded in the financial statements for the years ended December 31, 2023 and 2022. The Company recorded an income tax credit of approximately $(62) for the year ended December 31, 2023 related to state taxes. The effective tax rate for the years ended December 31, 2023 and 2022 is different from the tax benefit that would result from applying the statutory tax rates primarily due to the recognition of valuation allowances. In 2023, the valuation allowance decreased by approximately $(739), primarily related to temporary differences arising from Section 174 capitalized costs and stock based compensation.

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	12 Months Ended
STOCKHOLDERS’ EQUITY	Dec. 31, 2023
Equity [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Series A Convertible Preferred Stock In January 1997, the Board of Directors authorized the creation of 30,000 class of Series A Convertible Preferred Stock with a par value of $0.01. The Series A Convertible Preferred Stock is convertible into an equal number of common shares at the holder’s option, subject to adjustment for anti-dilution. The holders of Series A Convertible Preferred Stock are entitled to receive dividends as and if declared by the Board of Directors. In the event of liquidation or dissolution of the Company, the holders of Series A Convertible Preferred Stock are entitled to receive all accrued dividends, if applicable, plus the liquidation price of $1.00 per share. As of December 31, 2023, and 2022, there were no outstanding shares of Series A Convertible Preferred Stock. Stock-based Compensation To retain and attract qualified personnel necessary for the success of the Company, the Company adopted the 2015 Omnibus Incentive Plan (the “Plan”) covering up to 5,236,000 of the Company’s common shares, pursuant to which officers, directors, key employees and consultants to the Company are eligible to receive incentive stock options, nonqualified stock options and restricted stock units. All the equity compensation plans prior to Company’s 2015 Omnibus Incentive Plan have been closed. The Compensation Committee of the Board of Directors administers this Plan and determines the terms and conditions of stock options granted, including the exercise price. This Plan generally provides that all stock options will expire within ten years of the date of grant. Incentive stock options granted under this Plan must be granted at an exercise price that is not less than the fair market value per share at the date of the grant and the exercise price must not be less than 110% of the fair market value per share at the date of the grant for grants to persons owning more than 10% of the voting stock of the Company. This Plan also entitles non-employee directors to receive grants of non-qualified stock options as approved by the Board of Directors. The Company uses the Black-Scholes option pricing model to value the options on the grant date. The table below presents the weighted average expected life of the stock options in years. The Company uses the simplified method for all stock options to estimate the expected life of the option and assumes that stock options will be exercised evenly over the period from vesting until the awards expire. Volatility is determined using changes in historical stock prices. The interest rate for periods within the expected life of the award is based on U.S. Treasury yield curve in effect on the grant date. Options, generally, vest from one year to four years. The compensation expense is recognized over the requisite service period on a straight-line basis, reduced by forfeitures as they occur. Certain option awards are classified as liability awards. The fair values of these awards are determined at each reporting period utilizing a Black Scholes option pricing model, and the associated compensation expense (credit) for the reporting period is recorded. The Company recorded $(50) and $(324) of credits to stock-based compensation expense in the years ended December 31, 2023 and 2022, respectively, as a result of the change in fair value of these awards. The fair value of the Company’s stock options granted in 2023 that are being classified as equity awards were estimated using the Black-Scholes option pricing model with the following assumptions and weighted average fair values: Year Ended Valuation assumptions: Grant price $2.44 – $3.78 Exercise price $2.44 – $3.78 Expected dividend yield 0 % Expected volatility 73.77% – 86.24% Expected life (in years) 2.50 – 3.75 Risk-free interest rate 4.19% – 4.65% The fair value of the Company’s stock options granted in the year ended December 31, 2019, that are being classified as liability awards were marked-to-market using the Black-Scholes option pricing model with the following assumptions and weighted average fair values: Year Ended Valuation assumptions: Exercise price $2.68 Expected dividend yield 0 % Expected volatility range for grants after mark-to-market adjustment 79.88% - 82.02% Expected life (in years) for grants after mark-to-market adjustment 0.08 – 0.54 Risk-free interest rate range for grants after mark-to-market adjustment 4.80% - 5.59% Stock option activity during the periods indicated below was as follows: Number of Shares Subject to Issuance Weighted- average Exercise Price Weighted- average Remaining Aggregate Intrinsic Value Outstanding at December 31, 2021 496,424 $ 6.13 3.03 years $ 528 Granted 732,228 2.14 Forfeited (108,408) 4.53 Outstanding at December 31, 2022 1,120,244 $ 3.68 3.50 years $ 84 Granted 627,507 2.91 Forfeited (595,037) 4.05 Exercised — — Outstanding at December 31, 2023 1,152,714 $ 3.07 3.18 years $ 38 Exercisable at December 31, 2023 550,964 $ 3.47 2.33 years $ 23 The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they all exercised their options on December 31, 2023. This amount changes based upon the fair market value of the Company’s stock. The following is a summary of stock options as of December 31, 2023: Options Outstanding Options Exercisable Range of Exercise Prices Number of Weighted- Weighted- Number of Weighted- $1.71 to $3.69 1,024,398 3.95 years $ 2.47 484,081 $ 2.35 $3.78 to $11.50 128,316 2.85 years $ 8.00 66,883 $ 11.50 1,152,714 3.18 years $ 3.07 550,964 $ 3.47 The weighted-average fair value of the options granted during the year ended December 31, 2023 is $2.91. All stock options have been issued with an exercise price that is equal or above the fair market value of the Company’s Common Stock on the date of grant. Restricted Stock Units The Company periodically issues Restricted Stock Units (“RSUs”) which are equity-based instruments that may be settled in shares of common stock of the Company. The Company issues RSUs to certain directors as compensation which vest with the passage of time. The vesting of all RSUs is contingent on continued board and employment services. The compensation expense incurred by the Company for RSUs is based on the closing market price of the Company’s common stock on the date of grant, is amortized on a straight-line basis over the requisite service period and charged to operating expenses with a corresponding increase to additional paid-in capital, reduced by forfeitures when they occur. Restricted stock unit activity during the periods indicated below is as follows: Number of Weighted Outstanding at December 31, 2021 408,376 $ 10.43 Granted 139,958 2.23 Forfeited (36,445) 10.35 Vested and Settled in shares (296,997) 8.03 Outstanding at December 31, 2022 214,892 $ 8.43 Granted 249,412 2.34 Forfeited (70,959) 10.04 Vested and Settled in shares (332,845) 4.29 Outstanding December 31, 2023 60,500 $ 4.23 Performance Stock Units On August 7, 2020, the Company issued 265,942 Performance Stock Units (PSUs) to its officers and certain employees as compensation (“PSU Plan”). 50% of the PSUs were to vest based on the Company’s market price and 50% were to vest based on the Company’s Adjusted EBITDA. Both the conditions were to occur over a specified time and were contingent on continued employment services. On November 4, 2021, the Company amended its PSU Plan so that 100% of the PSUs will vest based on the Company’s market price as the sole vesting criteria. As a result of this amendment, the Adjusted EBITDA performance metric is no longer a vesting criterion. The fair value of these awards with a market condition was estimated, at the date of grant, using the Monte Carlo Simulation model with compensation expense being determined on the closing market price of the Company’s common stock on the date of grant and is amortized ratably on a straight-line basis over the requisite service period. Following the amendment mentioned above which provided that the Company's market price is the sole vesting criteria for these awards, compensation expense is charged to operating expenses with a corresponding increase to additional paid-in capital and is not reversed if the vesting criteria is not met. All outstanding PSUs vested during the year ended December 31, 2023 and as of December 31, 2023 there were no outstanding PSUs. Number of Weighted Outstanding at December 31, 2021 228,498 $ 7.91 Forfeited (50,810) 7.91 Outstanding at December 31, 2022 177,688 $ 7.91 Forfeited (88,844) 7.91 Vested and settled in shares (88,844) 7.91 Outstanding at December 31, 2023 — $ — As of December 31, 2023, there was $822 of total unrecognized compensation costs, related to all unvested stock options, and RSUs. These costs are expected to be recognized as compensation expense over a weighted average period of approximately 1.96 years. Stock-based compensation expense for the years ended December 31, 2023 and 2022 is as follows: Years Ended December 31, 2023 2022 Stock options $ 666 $ 382 Restricted stock units 930 1,342 Performance stock units — 731 $ 1,596 $ 2,455 Stock-based compensation is included in operating expenses as follows: Years Ended December 31, 2023 2022 Selling, general and administrative $ 1,358 $ 1,789 Research and development 238 666 $ 1,596 $ 2,455 As of December 31, 2023, the Company had 1,138,925 shares available for future grants under the Company’s equity compensation plans. Warrants

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
COMMITMENTS AND CONTINGENCIES	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Leases The Company leases an office in Melville, New York. Rent expense, which includes utilities, was $68 and $78 for the years ended December 31, 2023 and 2022 and is included in Selling, general and administrative expenses on the Statement of Operations. The Company determines if an arrangement is a lease at lease inception. The arrangement is a lease if it conveys the right to the Company to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The Company did not have an Operating Lease ROU or Operating Lease Liability as of December 31, 2023, as its office lease is on a month-to-month term and allows for either party to terminate the lease without a significant penalty. Legal Proceedings The Company is not aware of any infringement by our products or technology on the proprietary rights of others. From time to time, the Company may be involved in lawsuits, claims, investigations and proceedings, consisting of intellectual property, commercial, employment and other matters, which arise in the ordinary course of business. In accordance with GAAP, the Company records a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, ruling, advice of legal counsel and other information and events pertaining to a particular case. Litigation is inherently unpredictable. If any unfavorable ruling was to occur in any specific period or if a loss becomes probable and estimable, there exists the possibility of a material adverse impact on the Company’s results of operations, financial position or cash flows. As of December 31, 2023, no material amounts are recorded related to legal proceedings on the balance sheets. The Company recently received a class action complaint in March 2024, and while we are unable to fully assess the probability and outcome of the matter due to recency of the filing, the Company does not currently believe that a material loss is probable. As such, the Company has not recognized a liability and intends to fully defend the matter. Cash Incentive Plans In May 2020, the Board implemented a 2020 separate executive incentive bonus plan (“the 2020 Bonus Plan”) with the Company’s executive management team. Each agreement, under the 2020 Bonus Plan, is based on certain goals achieved by the Company plus individual achievements by each executive. In June 2020, the Company’s executive management team created a 2020 Employee Incentive Plan for all the Company’s non-executives and non-sales personnel. The incentive payment is based on the Company attaining certain revenue goals for the calendar year 2023 and is based as a percentage of the employee’s salary. At December 31, 2023 and 2022, this bonus liability for the executive and employee bonus plans amounted to $824 and $846 and is included in the Accrued Expenses on the Balance Sheets as well as the Accrued Expenses table in Note 7.

RETIREMENT PLAN

RETIREMENT PLAN	12 Months Ended
RETIREMENT PLAN	Dec. 31, 2023
Retirement Benefits [Abstract]
RETIREMENT PLAN	RETIREMENT PLAN

REVISION OF PRIOR PERIOD FINANC

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS	12 Months Ended
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS	Dec. 31, 2023
Accounting Changes and Error Corrections [Abstract]
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS	REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS In connection with the preparation of its financial statements for the year ended December 31, 2023, the Company determined that it had a historical state sales and use tax liability related to prior periods. The Company is required and subject to collect and remit sales and use taxes in state and local jurisdictions where it has economic nexus. During the year ended December 31, 2023, the Company determined that a sales tax liability related to the periods of 2019 through 2023 was probable and determined an estimated liability for sales transactions processed in jurisdictions where it had not previously reported. The Company determined that its previously issued financial statements for the period ended December 31, 2022 did not reflect the liability that was estimated to exist for that period. The correction of these errors had no effect on the total cash flows from operations, investing, or financing of the Company. All financial statements and footnotes presented herein have been adjusted to reflect the revisions below. As of March 31, 2022 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 1,768 605 $ 2,373 Accumulated deficit $ (128,365) (605) $ (128,970) Total stockholders’ equity $ 18,938 (605) $ 18,333 As of June 30, 2022 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 2,321 677 $ 2,998 Accumulated deficit $ (129,463) (677) $ (130,140) Total stockholders’ equity $ 18,360 (677) $ 17,683 As of September 30, 2022 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 2,036 751 $ 2,787 Accumulated deficit $ (130,187) (751) $ (130,938) Total stockholders’ equity $ 18,332 (751) $ 17,581 As of December 31, 2022 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 2,319 837 $ 3,156 Accumulated deficit $ (130,748) (837) $ (131,585) Total stockholders’ equity $ 18,504 (837) $ 17,667 As of March 31, 2023 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 2,475 908 $ 3,383 Accumulated deficit $ (132,064) (908) $ (132,972) Total stockholders’ equity $ 17,830 (908) $ 16,922 As of June 30, 2023 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 1,980 984 $ 2,964 Accumulated deficit $ (132,841) (984) $ (133,825) Total stockholders’ equity $ 17,337 (984) $ 16,353 As of September 30, 2023 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 2,350 1,064 $ 3,414 Accumulated deficit $ (133,485) (1,064) $ (134,549) Total stockholders’ equity $ 17,071 (1,064) $ 16,007 For the Three Months Ended March 31, 2022 As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 2,943 76 $ 3,019 Total operating expenses $ 4,547 76 $ 4,623 Loss from operations $ (1,468) (76) $ (1,544) Net loss $ (1,468) (76) $ (1,544) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.08) $ — $ (0.08) For the Three Months Ended June 30, 2022 For the Six Months Ended June 30, 2022 As Previously Reported Adjustment As adjusted As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 3,124 72 $ 3,196 $ 6,068 148 $ 6,216 Total operating expenses $ 4,742 72 $ 4,814 $ 9,289 148 $ 9,437 Loss from operations $ (1,098) (72) $ (1,170) $ (2,566) (148) $ (2,714) Net loss $ (1,098) (72) $ (1,170) $ (2,566) (148) $ (2,714) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.06) $ — $ (0.06) $ (0.14) $ — $ (0.14) For the Three Months Ended September 30, 2022 For the Nine Months Ended September 30, 2022 As Previously Reported Adjustment As adjusted As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 2,917 74 $ 2,991 $ 8,985 222 $ 9,207 Total operating expenses $ 4,378 74 $ 4,452 $ 13,667 222 $ 13,889 Loss from operations $ (724) (74) $ (798) $ (3,290) (222) $ (3,512) Net loss $ (724) (74) $ (798) $ (3,290) (222) $ (3,512) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.04) $ — $ (0.04) $ (0.17) $ (0.02) $ (0.19) For the Year Ended December 31, 2022 As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 12,399 308 $ 12,707 Total operating expenses $ 18,413 308 $ 18,721 Loss from operations $ (3,722) (308) $ (4,030) Net loss $ (3,851) (308) $ (4,159) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.20) $ (0.02) $ (0.22) For the Three Months Ended March 31, 2023 As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 3,924 71 $ 3,995 Total operating expenses $ 5,232 71 $ 5,303 Loss from operations $ (1,310) (71) $ (1,381) Net loss $ (1,316) (71) $ (1,387) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.07) $ — $ (0.07) For the Three Months Ended June 30, 2023 For the Six Months Ended June 30, 2023 As Previously Reported Adjustment As adjusted As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 3,861 76 $ 3,937 $ 7,784 147 $ 7,931 Total operating expenses $ 5,137 76 $ 5,213 $ 10,368 147 $ 10,515 Loss from operations $ (773) (76) $ (849) $ (2,082) (147) $ (2,229) Net loss $ (777) (76) $ (853) $ (2,093) (147) $ (2,240) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.04) $ — $ (0.04) $ (0.11) $ (0.01) $ (0.12) For the Three Months Ended September 30, 2023 For the Nine Months Ended September 30, 2023 As Previously Reported Adjustment As adjusted As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 3,597 80 $ 3,677 $ 11,382 227 $ 11,609 Total operating expenses $ 5,147 80 $ 5,227 $ 15,516 227 $ 15,743 Loss from operations $ (815) (80) $ (895) $ (2,898) (227) $ (3,125) Net loss $ (644) (80) $ (724) $ (2,737) (227) $ (2,964) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.03) $ (0.01) $ (0.04) $ (0.14) $ (0.01) $ (0.15) For the year ended December 31, 2021 As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (7,478) (529) $ (8,007) Accumulated deficit $ (126,897) (529) $ (127,426) Total Stockholders’ Equity $ 19,577 (529) $ 19,048 For the Three Months Ended March 31, 2022 For the Three Months Ended March 31, 2023 As Previously Adjustment As adjusted As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (1,468) (76) $ (1,544) $ (1,316) (71) $ (1,387) Accumulated deficit $ (128,365) (605) $ (128,970) $ (132,064) (908) $ (132,972) Total Stockholders’ Equity $ 18,938 (605) $ 18,333 $ 17,830 (908) $ 16,922 For the Three Months Ended June 30, 2022 For the Three Months Ended June 30, 2023 As Previously Adjustment As adjusted As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (1,098) (72) $ (1,170) $ (777) (76) $ (853) Accumulated deficit $ (129,463) (677) $ (130,140) $ (132,841) (984) $ (133,825) Total Stockholders’ Equity $ 18,360 (677) $ 17,683 $ 17,337 (984) $ 16,353 For the Three Months Ended September 30, 2022 For the Three Months Ended September 30, 2023 As Previously Adjustment As adjusted As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (724) (74) $ (798) $ (644) (80) $ (724) Accumulated deficit $ (130,187) (751) $ (130,938) $ (133,485) (1,064) $ (134,549) Total Stockholders’ Equity $ 18,332 (751) $ 17,581 $ 17,071 (1,064) $ 16,007 For the Six Months Ended June 30, 2022 For the Six Months Ended June 30, 2023 As Previously Adjustment As adjusted As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (2,566) (148) $ (2,714) $ (2,093) (147) $ (2,240) Accumulated deficit $ (129,463) (677) $ (130,140) $ (132,841) (984) $ (133,825) Total Stockholders’ Equity $ 18,360 (677) $ 17,683 $ 17,337 (984) $ 16,353 For the Nine Months Ended September 30, 2022 For the Nine Months Ended September 30, 2023 As Previously Adjustment As adjusted As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (3,290) (222) $ (3,512) $ (2,737) (227) $ (2,964) Accumulated deficit $ (130,187) (751) $ (130,938) $ (133,485) (1,064) $ (134,549) Total Stockholders’ Equity $ 18,332 (751) $ 17,581 $ 17,071 (1,064) $ 16,007 For the year ended December 31, 2022 As Previously Adjustment As STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (3,851) (308) $ (4,159) Accumulated deficit $ (130,748) (837) $ (131,585) Total Stockholders’ Equity $ 18,504 (837) $ 17,667 For the Three Months Ended March 31, 2022 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (1,468) (76) $ (1,544) Increase (decrease) in accounts payable and accrued expenses $ (1,149) 76 $ (1,073) For the Six Months Ended June 30, 2022 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (2,566) (148) $ (2,714) Increase (decrease) in accounts payable and accrued expenses $ (497) 148 $ (349) For the Nine Months Ended September 30, 2022 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (3,290) (222) $ (3,512) Increase (decrease) in accounts payable and accrued expenses $ (588) 222 $ (366) For the year ended December 31, 2022 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (3,851) (308) $ (4,159) Increase (decrease) in accounts payable and accrued expenses $ (568) 308 $ (260) For the Three Months Ended March 31, 2023 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (1,316) (71) $ (1,387) Increase (decrease) in accounts payable and accrued expenses $ 712 71 $ 783 For the Six Months Ended June 30, 2023 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (2,093) (147) $ (2,240) Increase (decrease) in accounts payable and accrued expenses $ (22) 147 $ 125 For the Nine Months Ended September 30, 2023 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (2,737) (227) $ (2,964) Increase (decrease) in accounts payable and accrued expenses $ 204 227 $ 431

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands

3 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Jun. 30, 2023

Mar. 31, 2023

Sep. 30, 2022

Jun. 30, 2022

Mar. 31, 2022

Mar. 31, 2021

Jun. 30, 2023

Jun. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2023

Dec. 31, 2022

Pay vs Performance Disclosure

Net loss

$ (724)

$ (853)

$ (1,387)

$ (798)

$ (1,170)

$ (1,544)

$ (8,007)

$ (2,240)

$ (2,714)

$ (2,964)

$ (3,512)

$ (1,980)

$ (4,159)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	The preparation of the Company’s financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the Company’s financial statements and accompanying notes.
Use of Estimates	Significant estimates and assumptions that affect amounts reported in the financial statements include impairment consideration and valuation of goodwill and intangible assets, deferred tax valuation allowances, allowance for doubtful accounts, revenue recognition (including breakage revenue) and the fair value of stock options granted under the Company’s Equity compensation plan. Due to the inherent uncertainties involved in making estimates, actual results reported in future periods may be different from those estimates.
Allowance for Credit Losses	Allowance for Credit Losses Effective January 1, 2023 Intellicheck applied the new standard ASU 2016-13, codified as ASC 326. This impacts how the allowance for doubtful accounts is calculated. Prior to ASC-326, Intellicheck would not recognize bad debt expense until the loss from customer non-payment was probable of occurring. Under the new model, Intellicheck’s allowance for doubtful accounts reflects the Company’s estimate of all expected future credit losses from its current customer balances. Under the new guidance, the Company has applied a loss rate method which takes historical data as the basis for calculating the allowance amount, along with accounting for other factors like current and forecasted market conditions, and potential future impacts to the industry. In estimating whether accounts receivable will be collected, the Company performs evaluations of customers and continuously monitors collections and payments and estimates an allowance for credit losses based on collections experience to date and any specific collection issues that have been identified. The allowance for credit losses is recorded in the period in which revenue is recorded or when collection risk is identified.
Cash and Cash Equivalents	Cash and Cash Equivalents We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents. Our cash and cash equivalents consist primarily of both cash on deposits with banks, which are maintained with major financial institutions in the United States, and money market funds. Accounts at each
Short-term investments	Short-term investments
Long-Lived Assets and Impairment of Long-Lived Assets	Long-Lived Assets and Impairment of Long-Lived Assets The Company’s long-lived assets include property and equipment, goodwill, and intangible assets. The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable in accordance with Accounting Standards Codification (“ASC”) 350 (“ Intangibles – Goodwill and Other ”) and ASC 360 (“ Property, Plant and Equipment ”). To determine recoverability of its long-lived assets, the Company evaluates the probability that future undiscounted net cash flows, without interest charges, will be less than the carrying amount of the assets. Impairment is measured at fair value.
Property and Equipment	Property and Equipment three
Goodwill	Goodwill Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC 350, the Company tests goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assesses qualitative factors to determine whether it is necessary to perform step one of the quantitative goodwill impairment test. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.
Intangible Assets	Intangible Assets Intangible assets include patents, copyrights, developed technology and capitalized software development costs. The Company amortizes these assets on a straight-line basis over their estimated useful lives, as it represents the pattern of economic benefits consumed. There were no impairment charges recognized for the years ended December 31, 2023 and 2022. See Note 5. We capitalize internal-use software costs which includes costs incurred in connection with the development of new software solutions and enhancements to existing software solutions that are expected to result in increased functionality. The costs incurred in the preliminary stages of development are expensed as incurred. Once the software has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is complete and available for its intended use. We evaluate the useful lives of these assets and test for impairment whenever events or
Revenue Recognition and Deferred Revenue and Shipping Costs and Sales Taxes	Revenue Recognition and Deferred Revenue General Most license fees and services revenue are generated from a combination of fixed-price and per-scan contracts. Under the per-scan revenue model, customers are charged a fee each time the customer scans an identity document, such as a driver’s license, with the Company’s software. Under the fixed-price revenue model customers are charged a fixed monthly fee either per device or physical business location to access the Company’s software. Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration expected to be received in exchange for those goods or services. The Company measures revenue based on the consideration specified in a customer arrangement, and revenue is recognized when the performance obligations in an arrangement are satisfied. A performance obligation is a promise in a contract to transfer a distinct service to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when, or as, the customer receives the benefit of the performance obligation. Customers typically receive the benefit of the Company’s services as they are performed. The Company's performance obligations are satisfied over time, and as a result, we may follow the right to invoice practical expedient meaning we recognize revenue monthly as invoiced based on our contract terms. The Company has an additional revenue model where customers purchase a predetermined number of transactions for the term of the contract. Customers are charged a fixed monthly fee for a set number of scans (fixed consideration), with any overages charged on a per scan basis (variable consideration). The Company estimates the amount of unused transactions at the end of each contract period and recognizes a portion of that revenue as breakage revenue each reporting period. If the Company expects the customer to use all transactions in the specified service period, the Company will recognize the transaction price as revenue in the specified service period as the promised units of service are transferred to the customer. Alternatively, if the Company expects that the customer cannot or will not use all transactions in the specified service period (referred to as “breakage”), the Company will recognize the estimated breakage amount as revenue ratably over the service period in proportion to the revenue that the Company will recognize for actual transactions used by the customer in the service period. The company does not estimate the variable consideration at any point; rather we calculate and recognize the variable portion at the end of the contract term since these contracts are considered monthly due to the termination clauses included within them. The fixed and variable performance obligations are recognized monthly based on the contract terms. Invoicing is based on schedules established in customer contracts. Payment terms are generally established from 30 to 60 days from the invoice date. Accordingly, the Company has determined that its contracts do not include a significant financing component. Product returns are estimated and recorded as a reduction to revenue, however, such amounts have been immaterial. The Company has not capitalized any costs to obtain a contract as the period of amortization for these associated costs would have been recognized over a period that is one year or less and the Company elected the practical expedient to expense those costs as incurred. Nature of goods and services The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each: Software as a Service (SaaS) Software as a service (SaaS) for hosted subscription services requires the Company to provide a stand-ready obligation and allows customers to access a set of data for a predetermined period of time. As the customer obtains access at a point in time but continues to have access for the remainder of the subscription period, the customer is considered to simultaneously receive and consume the benefits provided by the entity’s performance as the entity performs. Accordingly, the revenue should be recognized over time, under the fixed pricing model, based on the usage of the hosted subscription services, which can vary from month to month. Under the per-scan revenue model, the customer requires access to the Company's hosted subscription service but revenue is recognized over time as the customer scans an identity document. Equipment Revenue Revenue from the sale of equipment is recognized at a point in time. The point in time that the revenue is recognized is when the customer has control of the equipment which is when the customer receives the benefit and the Company’s performance obligation has been satisfied. Depending on the contract terms, that could either be at the time the equipment is shipped or at the time the equipment is received. Other Revenue Other Revenues, which historically have not been material, consist primarily of revenues from other subscription and support services, and extended warranties. The Company’s revenues from other subscription and support services includes jurisdictional updates to certain commercial customers and support services particularly to its Defense ID® customers. These subscriptions require continuing service or post contractual customer support and performance. As the customer obtains access at a point in time but continues to have access for the remainder of the subscription period, the customer is considered to simultaneously receive and consume the benefits provided by the Company’s performance as the Company performs. Accordingly, the revenue is recognized over time based on usage, which can vary from month to month. The revenue is typically based on a formula such as number of locations in a given month multiplied by a fee per location. Extended warranty revenues are generated when a warranty is provided to the customer separately of other performance obligations when the equipment is sold. As the customer obtains access at a point in time and continues to have access for the remainder of the warranty term, the customer is considered to simultaneously receive and consume the benefits provided by the Company’s performance as the Company performs. The related revenue is recognized ratably over the specified term of the warranty period. The extended warranty is separate from the Company’s standard warranty that it receives from its vendor, which is typically one year. Shipping Costs The Company’s shipping and handling costs related to sales are included in cost of revenues for all periods presented. All other shipping and handling costs are included as a component of selling, general and administrative expenses within the Statements of Operations. Sales Taxes Sales and other taxes collected from customers and remitted to governmental authorities are presented on a net basis and thus excluded from revenues.
Advertising Costs	Advertising Costs.
Loss Contingencies and Legal Costs	Loss Contingencies and Legal Costs The Company accrues loss contingencies that are believed to be probable and can be reasonably estimated. As events evolve during the administration and litigation process and additional information becomes known, the Company reassesses its estimates related to loss contingencies. Legal costs are expensed in the period in which the costs are incurred.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with ASC 740, “ Income Taxes
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company adheres to the provisions of ASC 820, “ Fair Value Measurement ” which requires the Company to calculate the fair value of financial instruments and include this additional information in the notes to financial statements when the fair value of those financial instruments is different than the book value. The Company’s financial instruments include cash and cash equivalents, short-term investments, accounts receivable, other current assets, accounts payable and accrued expenses. At December 31, 2023 and 2022, the carrying value of the Company’s financial instruments approximated fair value, due to their short-term nature. Financial Accounting Standards Board (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: •Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. The Company's Level 1 assets consisted primarily of cash and cash equivalents as well as short-term investments totaling approximately $8,980 and $10,076 as of December 31, 2023 and 2022, respectively. •Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies. The Company had $4 and $54 of Level 2 liabilities as of December 31, 2023 and December 31, 2022 respectively, for the liability-classified stock options. The fair value of these awards were determined by utilizing a Black-Scholes option pricing model. •Level 3—Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when the fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The Company had no Level 3 assets or liabilities as of December 31, 2023 and December 31, 2022. There were no transfers into or out of Level 3 measurements in 2023 and 2022.
Business Concentration and Credit Risk	Business Concentration and Credit Risk Financial instruments, which subject the Company to concentrations of credit risk, consist primarily of cash. The Company maintains cash at two financial institutions. The Company performs periodic evaluations of the relative credit standing of these institutions. The Company’s sales are principally made to large retail customers, financial institutions concentrated in the United States and to U.S. government entities. The Company performs ongoing credit evaluations, generally does not require collateral, and establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of customers, historical trends, and other market and economic information.
Net Loss Per Share	Net Loss Per Share Basic net loss per share is computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted average number of shares of common stock and potentially dilutive common stock equivalents outstanding during the period. The dilutive effect of these common stock equivalents comprising of outstanding options, warrants and restricted stock is reflected in diluted earnings per share by application of the treasury stock method. The calculation of diluted net loss per share excludes all anti-dilutive shares. In a period of net loss, all common stock equivalents are considered anti-dilutive.
Stock-based Compensation	Stock-based Compensation The Company accounts for the issuance of equity awards to employees in accordance ASC 718 (“ Compensation - Stock Compensation ) and ASC 505 (“ Equity
Segment Information	Segment Information The Company adheres to the provisions of ASC 280 (“ Segment Reporting ”), which establishes standards for the way public business enterprises report information about operating segments in annual financial statements and requires that those enterprises report selected information about operating segments in financial statements issued to shareholders. The Company’s Chief Operating Decision Maker, its Chief Executive Officer (“CEO”), reviews the financial information presented for purposes of allocating resources and evaluating its financial performance. Accordingly, the Company has determined that it operates in a single reportable segment. All of the Company’s long-lived assets are located in the United States. Since the Company operates in one operating segment, all required financial segment information can be found in the financial statements.
Research and Development	Research and Development Research and development expenses are expensed as incurred and consist primarily of employee-related expenses (such as salaries, taxes, benefits and stock-based compensation), allocated overhead costs and outside services costs related to the development and improvement of the Company's SaaS applications.
Recent Accounting Pronouncements and Revision of Previously Reported Financial Statements	Recent Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13") to measure credit losses on financial instruments, including trade receivables. The guidance eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate can now reflect an entity’s current estimate of all future expected credit losses. Under the previous guidance, an entity only considered past events and current conditions. The Company concluded that the adoption of this standard, on January 1, 2023, did not have a material impact on its financial statements because of the short-term nature of its outstanding accounts receivable and there have been no significant forward-looking economic conditions identified by the Company that would impact its short-term investments. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances reporting requirements under Topic 280. The enhanced disclosure requirements include: title and position of the Chief Operating Decision Maker (CODM), significant segment expenses provided to the CODM, extending certain annual disclosures to interim periods, clarifying single reportable segment entities must apply ASC 280 in its entirety, and permitting more than one measure of segment profit or loss to be reported under certain circumstances. This change is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. This change will apply retrospectively to all periods presented. The Company is currently evaluating the impact of this ASU on its financial statements. In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740), which establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing requirements. The new guidance requires consistent categorization and greater disaggregation of information in the rate reconciliation, as well as further disaggregation of income taxes paid. This change is effective for annual periods beginning after December 15, 2024. This change will apply on a prospective basis to annual financial statements for periods beginning after the effective date. However, retrospective application in all prior periods presented is permitted. The Company is currently evaluating the impact of this ASU on its financial statements. Revision of Previously Reported Financial Statements

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Tables)	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of Revenue Disaggregated by Product and Service and Timing of Revenue Recognition	In the following tables, revenue is disaggregated by product and service and the timing of revenue recognition. The table also includes a reconciliation of the disaggregated revenue. For the Years Ended December 31, 2023 2022 Products and services Software as a Service (SaaS) $ 18,595 $ 15,728 Other 146 26 Equipment 165 212 $ 18,906 $ 15,966 Timing of revenue recognition Products transferred at a point in time $ 311 $ 238 Services transferred over time 18,595 15,728 $ 18,906 $ 15,966
Scheduled of Revenue Expected to be Recognized Related to Performance Obligations	The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the reporting period: 2024 2025 2026 Total Software as a Service (SaaS) $ 2,201 $ — $ — $ 2,201 Other 8 — — 8 $ 2,209 $ — $ — $ 2,209
Schedule of Basic and Diluted Earnings Per Share	Years Ended 2023 2022 Numerator: Net Loss $ (1,980) $ (4,159) Denominator: Weighted average common shares – Basic 19,243,179 18,838,971 Weighted average common shares - Diluted 19,243,179 18,838,971 Net Loss per share – Basic $ (0.10) $ (0.22) Diluted $ (0.10) $ (0.22)
Summary of Common Stock Equivalents Excluded from Loss Per Diluted Share	The following table summarizes the common stock equivalents excluded from the 2023 and 2022 loss per diluted share because their effect would be anti-dilutive: 2023 2022 Stock options 1,152,714 1,120,244 Restricted stock 60,500 214,892 Performance stock units — 177,688 Total 1,213,214 1,512,824

CASH EQUIVALENTS AND SHORT-TE_2

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables)	12 Months Ended
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables)	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Cash and Cash Equivalents and Short-Term Investments	The following table summarizes the fair value of cash and cash equivalents, and short-term investments as well as any gross unrealized holding gains and losses as of December 31, 2023. Due to the nature of these assets and the short-term nature of the U.S. treasury notes being held to maturity, both these cash and cash equivalents and short-term investments fall under the Level 1 fair value hierarchy as referenced in Note 2. As of December 31, 2023 Amortized cost Gross unrealized holding gains Gross unrealized holding losses Estimated fair value Cash and cash equivalents $ 3,980 $ — $ — $ 3,980 U.S. treasury notes (1) 5,000 — — 5,000 Total cash, cash equivalents and short-term investments $ 8,980 $ — $ — $ 8,980 As of December 31, 2022 Amortized cost Gross unrealized holding gains Gross unrealized holding losses Estimated fair value Cash and cash equivalents $ 5,196 $ — $ — $ 5,196 U.S. treasury notes (2) 4,880 3 (15) 4,868 Total cash, cash equivalents and short-term investments $ 10,076 $ 3 $ (15) $ 10,064 (1) These U.S. treasury notes are classified as "held-to-maturity" as they were purchased in August 2023 and will mature in January 2024. Any coupon payments or accretion of discounts from these short-term investments fall under "Interest and other income (expense)" in the Company's Statement of Operations. (2) These U.S. treasury notes were classified as "held-to-maturity" as they were purchased in December 2022 and matured in July 2023.

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
PROPERTY AND EQUIPMENT (Tables)	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment are comprised of the following as of December 31, 2023 and 2022: 2023 2022 Computer equipment and software $ 1,886 $ 1,796 Furniture and fixtures 139 139 Office equipment 618 614 2,643 2,549 Less – Accumulated depreciation (1,977) (1,800) $ 666 $ 749

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	12 Months Ended
GOODWILL AND INTANGIBLE ASSETS (Tables)	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Components of Intangible Assets	The following tables set forth the components of intangible assets as of December 31, 2023 and 2022: Estimated As of December 31, 2023 Adjusted Accumulated Net Patents and copyrights 2-17 years $ 375 $ (300) $ 75 Developed technology 5 years 400 (307) 93 Software development - 407 — 407 $ 1,182 $ (607) $ 575 Estimated As of December 31, 2022 Adjusted Accumulated Net Patents and copyrights 2-17 years $ 375 $ (275) $ 100 Developed technology 5 years 400 (227) 173 $ 775 $ (502) $ 273
Schedule of Acquisition Related Intangible Asset Amortization Expense	The following summarizes amortization of acquisition related intangible assets included in the Statement of Operations: Years Ended December 31, 2023 2022 Cost of revenues $ 95 $ 95 Selling, general and administrative 10 10 $ 105 $ 105
Schedule of Intangible Asset Future Amortization Expense	The Company expects amortization expense for the next five succeeding years will be as follows: 2024 $ 105 2025 39 2026 20 2027 4 2028 — $ 168

ACCRUED EXPENSES (Tables)

ACCRUED EXPENSES (Tables)	12 Months Ended
ACCRUED EXPENSES (Tables)	Dec. 31, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses are comprised of the following as of December 31, 2023 and 2022: 2023 2022 (As Adjusted) Professional fees $ 1 $ 259 Payroll and related 1,159 1,040 Incentive bonuses 824 846 Sales tax accrual 1,064 837 Other 197 174 $ 3,245 $ 3,156

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Provision for Income Taxes	The provision for income taxes as of December 31, 2023 and 2022 consists of the following: 2023 2022 Current: Federal $ (12) $ — State (50) 124 Total current tax (benefit) expense (62) 124 Deferred: Federal — — State — — Total deferred tax (benefits) expense — — (Benefit) Provision for income taxes $ (62) $ 124
Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of the statutory U.S. Federal rate to the Company’s effective tax rate as of December 31, 2023 and 2022 is as follows: 2023 2022 (As Adjusted) Federal income tax benefit at statutory rate 21.00 % 21.00 % State income taxes, net of federal benefit 0.25 (2.20) Other permanent items (0.30) (0.04) Stock-based compensation (9.94) (1.99) Lobbying expense (1.95) (0.92) Research and development tax credits (9.66) 9.92 Cumulative deferred adjustments (31.39) 26.14 Rate change (2.22) (18.06) Change in valuation allowance 36.20 (36.30) Other 1.07 (0.66) Effective income tax (benefit) expense rate 3.06 % (3.11) %
Schedule of Components of Deferred Tax Assets	Significant components of the Company’s deferred tax assets for federal and state income taxes as of December 31, 2023 and 2022 are as follows: 2023 2022 (As Adjusted) Deferred tax assets: Net operating loss carryforwards $ 5,625 $ 4,889 Payroll related accruals 256 333 Stock-based compensation 88 612 Intangible assets 90 89 Sec. 174 Capitalized costs 468 1,237 Sales tax accrual 245 197 Other 17 5 Depreciation 50 18 Research and development tax credits 708 906 Total deferred tax assets 7,547 8,286 Net deferred tax assets 7,547 8,286 Less: Valuation allowance (7,547) (8,286) Deferred tax assets, net of allowance $ — $ —

STOCKHOLDERS_ EQUITY (Tables)

STOCKHOLDERS’ EQUITY (Tables)	12 Months Ended
STOCKHOLDERS’ EQUITY (Tables)	Dec. 31, 2023
Equity [Abstract]
Schedule of Stock Option Valuation Assumptions for Equity Awards and Liability Awards	The fair value of the Company’s stock options granted in 2023 that are being classified as equity awards were estimated using the Black-Scholes option pricing model with the following assumptions and weighted average fair values: Year Ended Valuation assumptions: Grant price $2.44 – $3.78 Exercise price $2.44 – $3.78 Expected dividend yield 0 % Expected volatility 73.77% – 86.24% Expected life (in years) 2.50 – 3.75 Risk-free interest rate 4.19% – 4.65% The fair value of the Company’s stock options granted in the year ended December 31, 2019, that are being classified as liability awards were marked-to-market using the Black-Scholes option pricing model with the following assumptions and weighted average fair values: Year Ended Valuation assumptions: Exercise price $2.68 Expected dividend yield 0 % Expected volatility range for grants after mark-to-market adjustment 79.88% - 82.02% Expected life (in years) for grants after mark-to-market adjustment 0.08 – 0.54 Risk-free interest rate range for grants after mark-to-market adjustment 4.80% - 5.59%
Schedule of Stock Option Activity	Stock option activity during the periods indicated below was as follows: Number of Shares Subject to Issuance Weighted- average Exercise Price Weighted- average Remaining Aggregate Intrinsic Value Outstanding at December 31, 2021 496,424 $ 6.13 3.03 years $ 528 Granted 732,228 2.14 Forfeited (108,408) 4.53 Outstanding at December 31, 2022 1,120,244 $ 3.68 3.50 years $ 84 Granted 627,507 2.91 Forfeited (595,037) 4.05 Exercised — — Outstanding at December 31, 2023 1,152,714 $ 3.07 3.18 years $ 38 Exercisable at December 31, 2023 550,964 $ 3.47 2.33 years $ 23
Summary of Stock Options	The following is a summary of stock options as of December 31, 2023: Options Outstanding Options Exercisable Range of Exercise Prices Number of Weighted- Weighted- Number of Weighted- $1.71 to $3.69 1,024,398 3.95 years $ 2.47 484,081 $ 2.35 $3.78 to $11.50 128,316 2.85 years $ 8.00 66,883 $ 11.50 1,152,714 3.18 years $ 3.07 550,964 $ 3.47
Schedule of Restricted Stock Unit Activity	Restricted stock unit activity during the periods indicated below is as follows: Number of Weighted Outstanding at December 31, 2021 408,376 $ 10.43 Granted 139,958 2.23 Forfeited (36,445) 10.35 Vested and Settled in shares (296,997) 8.03 Outstanding at December 31, 2022 214,892 $ 8.43 Granted 249,412 2.34 Forfeited (70,959) 10.04 Vested and Settled in shares (332,845) 4.29 Outstanding December 31, 2023 60,500 $ 4.23
Schedule of Performance Stock Unit Activity	Number of Weighted Outstanding at December 31, 2021 228,498 $ 7.91 Forfeited (50,810) 7.91 Outstanding at December 31, 2022 177,688 $ 7.91 Forfeited (88,844) 7.91 Vested and settled in shares (88,844) 7.91 Outstanding at December 31, 2023 — $ —
Schedule of Stock-based Compensation Expense	Stock-based compensation expense for the years ended December 31, 2023 and 2022 is as follows: Years Ended December 31, 2023 2022 Stock options $ 666 $ 382 Restricted stock units 930 1,342 Performance stock units — 731 $ 1,596 $ 2,455
Schedule of Stock-based Compensation Included in Operating Expenses	Stock-based compensation is included in operating expenses as follows: Years Ended December 31, 2023 2022 Selling, general and administrative $ 1,358 $ 1,789 Research and development 238 666 $ 1,596 $ 2,455

REVISION OF PRIOR PERIOD FINA_2

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)	12 Months Ended
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)	Dec. 31, 2023
Accounting Changes and Error Corrections [Abstract]
Schedule of Financial Statements and Footnotes Presented as Adjusted	All financial statements and footnotes presented herein have been adjusted to reflect the revisions below. As of March 31, 2022 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 1,768 605 $ 2,373 Accumulated deficit $ (128,365) (605) $ (128,970) Total stockholders’ equity $ 18,938 (605) $ 18,333 As of June 30, 2022 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 2,321 677 $ 2,998 Accumulated deficit $ (129,463) (677) $ (130,140) Total stockholders’ equity $ 18,360 (677) $ 17,683 As of September 30, 2022 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 2,036 751 $ 2,787 Accumulated deficit $ (130,187) (751) $ (130,938) Total stockholders’ equity $ 18,332 (751) $ 17,581 As of December 31, 2022 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 2,319 837 $ 3,156 Accumulated deficit $ (130,748) (837) $ (131,585) Total stockholders’ equity $ 18,504 (837) $ 17,667 As of March 31, 2023 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 2,475 908 $ 3,383 Accumulated deficit $ (132,064) (908) $ (132,972) Total stockholders’ equity $ 17,830 (908) $ 16,922 As of June 30, 2023 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 1,980 984 $ 2,964 Accumulated deficit $ (132,841) (984) $ (133,825) Total stockholders’ equity $ 17,337 (984) $ 16,353 As of September 30, 2023 As Previously Reported Adjustment As adjusted BALANCE SHEET Accrued expenses $ 2,350 1,064 $ 3,414 Accumulated deficit $ (133,485) (1,064) $ (134,549) Total stockholders’ equity $ 17,071 (1,064) $ 16,007 For the Three Months Ended March 31, 2022 As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 2,943 76 $ 3,019 Total operating expenses $ 4,547 76 $ 4,623 Loss from operations $ (1,468) (76) $ (1,544) Net loss $ (1,468) (76) $ (1,544) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.08) $ — $ (0.08) For the Three Months Ended June 30, 2022 For the Six Months Ended June 30, 2022 As Previously Reported Adjustment As adjusted As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 3,124 72 $ 3,196 $ 6,068 148 $ 6,216 Total operating expenses $ 4,742 72 $ 4,814 $ 9,289 148 $ 9,437 Loss from operations $ (1,098) (72) $ (1,170) $ (2,566) (148) $ (2,714) Net loss $ (1,098) (72) $ (1,170) $ (2,566) (148) $ (2,714) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.06) $ — $ (0.06) $ (0.14) $ — $ (0.14) For the Three Months Ended September 30, 2022 For the Nine Months Ended September 30, 2022 As Previously Reported Adjustment As adjusted As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 2,917 74 $ 2,991 $ 8,985 222 $ 9,207 Total operating expenses $ 4,378 74 $ 4,452 $ 13,667 222 $ 13,889 Loss from operations $ (724) (74) $ (798) $ (3,290) (222) $ (3,512) Net loss $ (724) (74) $ (798) $ (3,290) (222) $ (3,512) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.04) $ — $ (0.04) $ (0.17) $ (0.02) $ (0.19) For the Year Ended December 31, 2022 As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 12,399 308 $ 12,707 Total operating expenses $ 18,413 308 $ 18,721 Loss from operations $ (3,722) (308) $ (4,030) Net loss $ (3,851) (308) $ (4,159) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.20) $ (0.02) $ (0.22) For the Three Months Ended March 31, 2023 As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 3,924 71 $ 3,995 Total operating expenses $ 5,232 71 $ 5,303 Loss from operations $ (1,310) (71) $ (1,381) Net loss $ (1,316) (71) $ (1,387) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.07) $ — $ (0.07) For the Three Months Ended June 30, 2023 For the Six Months Ended June 30, 2023 As Previously Reported Adjustment As adjusted As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 3,861 76 $ 3,937 $ 7,784 147 $ 7,931 Total operating expenses $ 5,137 76 $ 5,213 $ 10,368 147 $ 10,515 Loss from operations $ (773) (76) $ (849) $ (2,082) (147) $ (2,229) Net loss $ (777) (76) $ (853) $ (2,093) (147) $ (2,240) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.04) $ — $ (0.04) $ (0.11) $ (0.01) $ (0.12) For the Three Months Ended September 30, 2023 For the Nine Months Ended September 30, 2023 As Previously Reported Adjustment As adjusted As Previously Reported Adjustment As adjusted STATEMENT OF OPERATIONS Selling, general and administrative expenses $ 3,597 80 $ 3,677 $ 11,382 227 $ 11,609 Total operating expenses $ 5,147 80 $ 5,227 $ 15,516 227 $ 15,743 Loss from operations $ (815) (80) $ (895) $ (2,898) (227) $ (3,125) Net loss $ (644) (80) $ (724) $ (2,737) (227) $ (2,964) PER SHARE INFORMATION Loss per common share Basic and Diluted $ (0.03) $ (0.01) $ (0.04) $ (0.14) $ (0.01) $ (0.15) For the year ended December 31, 2021 As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (7,478) (529) $ (8,007) Accumulated deficit $ (126,897) (529) $ (127,426) Total Stockholders’ Equity $ 19,577 (529) $ 19,048 For the Three Months Ended March 31, 2022 For the Three Months Ended March 31, 2023 As Previously Adjustment As adjusted As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (1,468) (76) $ (1,544) $ (1,316) (71) $ (1,387) Accumulated deficit $ (128,365) (605) $ (128,970) $ (132,064) (908) $ (132,972) Total Stockholders’ Equity $ 18,938 (605) $ 18,333 $ 17,830 (908) $ 16,922 For the Three Months Ended June 30, 2022 For the Three Months Ended June 30, 2023 As Previously Adjustment As adjusted As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (1,098) (72) $ (1,170) $ (777) (76) $ (853) Accumulated deficit $ (129,463) (677) $ (130,140) $ (132,841) (984) $ (133,825) Total Stockholders’ Equity $ 18,360 (677) $ 17,683 $ 17,337 (984) $ 16,353 For the Three Months Ended September 30, 2022 For the Three Months Ended September 30, 2023 As Previously Adjustment As adjusted As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (724) (74) $ (798) $ (644) (80) $ (724) Accumulated deficit $ (130,187) (751) $ (130,938) $ (133,485) (1,064) $ (134,549) Total Stockholders’ Equity $ 18,332 (751) $ 17,581 $ 17,071 (1,064) $ 16,007 For the Six Months Ended June 30, 2022 For the Six Months Ended June 30, 2023 As Previously Adjustment As adjusted As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (2,566) (148) $ (2,714) $ (2,093) (147) $ (2,240) Accumulated deficit $ (129,463) (677) $ (130,140) $ (132,841) (984) $ (133,825) Total Stockholders’ Equity $ 18,360 (677) $ 17,683 $ 17,337 (984) $ 16,353 For the Nine Months Ended September 30, 2022 For the Nine Months Ended September 30, 2023 As Previously Adjustment As adjusted As Previously Adjustment As adjusted STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (3,290) (222) $ (3,512) $ (2,737) (227) $ (2,964) Accumulated deficit $ (130,187) (751) $ (130,938) $ (133,485) (1,064) $ (134,549) Total Stockholders’ Equity $ 18,332 (751) $ 17,581 $ 17,071 (1,064) $ 16,007 For the year ended December 31, 2022 As Previously Adjustment As STATEMENT OF STOCKHOLDERS’ EQUITY Net loss $ (3,851) (308) $ (4,159) Accumulated deficit $ (130,748) (837) $ (131,585) Total Stockholders’ Equity $ 18,504 (837) $ 17,667 For the Three Months Ended March 31, 2022 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (1,468) (76) $ (1,544) Increase (decrease) in accounts payable and accrued expenses $ (1,149) 76 $ (1,073) For the Six Months Ended June 30, 2022 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (2,566) (148) $ (2,714) Increase (decrease) in accounts payable and accrued expenses $ (497) 148 $ (349) For the Nine Months Ended September 30, 2022 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (3,290) (222) $ (3,512) Increase (decrease) in accounts payable and accrued expenses $ (588) 222 $ (366) For the year ended December 31, 2022 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (3,851) (308) $ (4,159) Increase (decrease) in accounts payable and accrued expenses $ (568) 308 $ (260) For the Three Months Ended March 31, 2023 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (1,316) (71) $ (1,387) Increase (decrease) in accounts payable and accrued expenses $ 712 71 $ 783 For the Six Months Ended June 30, 2023 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (2,093) (147) $ (2,240) Increase (decrease) in accounts payable and accrued expenses $ (22) 147 $ 125 For the Nine Months Ended September 30, 2023 As Previously Adjustment As Adjusted STATEMENT OF CASH FLOWS Net loss $ (2,737) (227) $ (2,964) Increase (decrease) in accounts payable and accrued expenses $ 204 227 $ 431

NATURE OF BUSINESS (Details)

NATURE OF BUSINESS (Details) - USD ($) $ in Thousands	3 Months Ended							6 Months Ended		9 Months Ended		12 Months Ended
NATURE OF BUSINESS (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ (724)	$ (853)	$ (1,387)	$ (798)	$ (1,170)	$ (1,544)	$ (8,007)	$ (2,240)	$ (2,714)	$ (2,964)	$ (3,512)	$ (1,980)	$ (4,159)
Net cash used in operating activities												(647)	(3,480)
Cash and cash equivalents												3,980	5,196
Short-term investments												5,000	4,880
Working capital												7,843
Accumulated deficit	$ 134,549	$ 133,825	$ 132,972	$ 130,938	$ 130,140	$ 128,970		$ 133,825	$ 130,140	$ 134,549	$ 130,938	$ 133,565	$ 131,585	$ 127,426

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	12 Months Ended
SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	Dec. 31, 2023 USD ($) financial_institution supplier segment	Dec. 31, 2022 USD ($)
Product Information [Line Items]
Goodwill, impairment charges	$ 0	$ 0
Intangible assets, impairment charges	0	0
Capitalized software development costs, impairment charges	0	0
Deferred revenue, current portion	2,209,000	906,000
Deferred revenue, noncurrent portion	0	1,000
Advertising costs	536,000	683,000
Equity awards liability	$ 4,000	54,000
Number of financial institutions \| financial_institution	2
Number of suppliers \| supplier	4
Number of reporting segments \| segment	1
Number of operating segments \| segment	1
Fair Value, Inputs, Level 1
Product Information [Line Items]
Cash, cash equivalents and short-term investments	$ 8,980,000	10,076,000
Fair Value, Inputs, Level 2
Product Information [Line Items]
Equity awards liability	$ 4,000	$ 54,000
Minimum
Product Information [Line Items]
Property and equipment, useful life	3 years
Maximum
Product Information [Line Items]
Property and equipment, useful life	7 years
Three Customers \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent	47%	52%
Three Customers \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent	66%
Customer One \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent	21%	22%
Customer One \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent	37%	37%
Customer Two \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent	14%	17%
Customer Two \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent	6%	11%
Customer Three \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent	12%	13%
Customer Three \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent	23%	1%
Four Customers \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent		63%
Customer Four \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent		14%

SIGNIFICANT ACCOUNTING POLICI_5

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Product Information [Line Items]
Revenue	$ 18,906	$ 15,966
Products transferred at a point in time
Product Information [Line Items]
Revenue	311	238
Services transferred over time
Product Information [Line Items]
Revenue	18,595	15,728
Software as a Service (SaaS)
Product Information [Line Items]
Revenue	18,595	15,728
Other
Product Information [Line Items]
Revenue	146	26
Equipment
Product Information [Line Items]
Revenue	$ 165	$ 212

SIGNIFICANT ACCOUNTING POLICI_6

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Revenue Performance Obligations (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 2,209
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 2,209
Revenue, remaining performance obligation, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, period	1 year
Software as a Service (SaaS)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 2,201
Software as a Service (SaaS) \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 2,201
Revenue, remaining performance obligation, period	1 year
Software as a Service (SaaS) \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, period	1 year
Software as a Service (SaaS) \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, period	1 year
Other
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 8
Other \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 8
Revenue, remaining performance obligation, period	1 year
Other \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, period	1 year
Other \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, period	1 year

SIGNIFICANT ACCOUNTING POLICI_7

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended							6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Numerator:
Net Loss	$ (724)	$ (853)	$ (1,387)	$ (798)	$ (1,170)	$ (1,544)	$ (8,007)	$ (2,240)	$ (2,714)	$ (2,964)	$ (3,512)	$ (1,980)	$ (4,159)
Weighted average common shares –
Basic (in shares)												19,243,179	18,838,971
Diluted (in shares)												19,243,179	18,838,971
Net Loss per share –
Basic (in dollars per share)	$ (0.04)	$ (0.04)	$ (0.07)	$ (0.04)	$ (0.06)	$ (0.08)		$ (0.12)	$ (0.14)	$ (0.15)	$ (0.19)	$ (0.10)	$ (0.22)
Diluted (in dollars per share)	$ (0.04)	$ (0.04)	$ (0.07)	$ (0.04)	$ (0.06)	$ (0.08)		$ (0.12)	$ (0.14)	$ (0.15)	$ (0.19)	$ (0.10)	$ (0.22)

SIGNIFICANT ACCOUNTING POLICI_8

SIGNIFICANT ACCOUNTING POLICIES - Summary of Common Stock Equivalents Excluded From Loss Per Diluted Share (Details) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	1,213,214	1,512,824
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	1,152,714	1,120,244
Restricted stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	60,500	214,892
Performance stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	0	177,688

CASH EQUIVALENTS AND SHORT-TE_3

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS - Schedule of Cash and Cash Equivalents and Short Term Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Amortized cost
Cash and cash equivalents	$ 3,980	$ 5,196
Fair Value, Inputs, Level 1
Amortized cost
Cash and cash equivalents	3,980	5,196
Total cash, cash equivalents and short-term investments	8,980	10,076
Gross unrealized holding gains
Total cash, cash equivalents and short-term investments	0	3
Gross unrealized holding losses
Total cash, cash equivalents and short-term investments	0	(15)
Estimated fair value
Cash and cash equivalents	3,980	5,196
Total cash, cash equivalents and short-term investments	8,980	10,064
U.S. treasury notes \| Fair Value, Inputs, Level 1
Amortized cost
U.S. treasury notes	5,000	4,880
Gross unrealized holding gains
Total cash, cash equivalents and short-term investments	0	3
Gross unrealized holding losses
Total cash, cash equivalents and short-term investments	0	(15)
Estimated fair value
U.S. treasury notes	$ 5,000	$ 4,868

CASH EQUIVALENTS AND SHORT-TE_4

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($) number_security	Dec. 31, 2022 USD ($) number_security
Schedule of Held-to-Maturity Securities [Line Items]
Short-term investments, realized gains or losses \| $	$ 206	$ 0
U.S. treasury notes \| Fair Value, Inputs, Level 1
Schedule of Held-to-Maturity Securities [Line Items]
Number of securities in unrealized loss position for more than 12 months \| number_security	0	0

PROPERTY AND EQUIPMENT - Schedu

PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,643	$ 2,549
Less – Accumulated depreciation	(1,977)	(1,800)
Property and equipment, net	666	749
Computer equipment and software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,886	1,796
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	139	139
Office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 618	$ 614

PROPERTY AND EQUIPMENT - Narrat

PROPERTY AND EQUIPMENT - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation	$ 177	$ 180

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Asset Components (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Adjusted Carrying Amount	$ 1,182	$ 775
Accumulated Amortization	(607)	(502)
Net	575	273
Patents and copyrights
Finite-Lived Intangible Assets [Line Items]
Adjusted Carrying Amount	375	375
Accumulated Amortization	(300)	(275)
Net	$ 75	$ 100
Patents and copyrights \| Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	2 years	2 years
Patents and copyrights \| Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	17 years	17 years
Developed technology
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	5 years	5 years
Adjusted Carrying Amount	$ 400	$ 400
Accumulated Amortization	(307)	(227)
Net	93	$ 173
Software development
Finite-Lived Intangible Assets [Line Items]
Adjusted Carrying Amount	407
Accumulated Amortization	0
Net	$ 407

GOODWILL AND INTANGIBLE ASSET_3

GOODWILL AND INTANGIBLE ASSETS - Schedule of Acquisition Related Intangible Asset Amortization Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Goodwill [Line Items]
Amortization expense	$ 105	$ 105
Cost of revenues
Goodwill [Line Items]
Amortization expense	95	95
Selling, general and administrative
Goodwill [Line Items]
Amortization expense	$ 10	$ 10

GOODWILL AND INTANGIBLE ASSET_4

GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Asset Future Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Net	$ 575	$ 273
Excluding Software Development
Finite-Lived Intangible Assets [Line Items]
2024	105
2025	39
2026	20
2027	4
2028	0
Net	$ 168

GOODWILL AND INTANGIBLE ASSET_5

GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Capitalized computer software costs	$ 407
Goodwill	$ 8,102	$ 8,102

DEBT (Details)

DEBT (Details) - USD ($)		1 Months Ended	12 Months Ended
DEBT (Details) - USD ($)	Jun. 17, 2022	Feb. 28, 2023	Dec. 31, 2023	Dec. 31, 2022	Feb. 06, 2019
Citi Personal Wealth Management \| Revolving Credit Facility \| Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity (up to)					$ 2,000,000
Amount outstanding			$ 0	$ 0
Unused availability			$ 2,000,000	$ 2,000,000
Citi Personal Wealth Management \| Revolving Credit Facility \| Line of Credit \| Base Rate \| Variable Rate Component One
Line of Credit Facility [Line Items]
Interest rate, basis spread			8.50%	7.50%
Citi Personal Wealth Management \| Revolving Credit Facility \| Line of Credit \| Base Rate \| Variable Rate Component Two
Line of Credit Facility [Line Items]
Interest rate, basis spread			(2.00%)	(2.00%)
Insurance Financing Arrangement, February 2023
Line of Credit Facility [Line Items]
Debt, face amount		$ 49,000
Interest rate		9.47%
Monthly loan payments		$ 5,000
Debt, term		11 months
Remaining commitment			$ 0
Insurance Financing Arrangement, June 2022
Line of Credit Facility [Line Items]
Debt, face amount	$ 319,000
Interest rate	4.05%
Monthly loan payments	$ 32,000
Debt, term	10 months
Remaining commitment			$ 0

ACCRUED EXPENSES - Schedule of

ACCRUED EXPENSES - Schedule of Components of Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Payables and Accruals [Abstract]
Professional fees	$ 1				$ 259
Payroll and related	1,159				1,040
Incentive bonuses	824				846
Sales tax accrual	1,064				837
Other	197				174
Accrued expenses	$ 3,245	$ 3,414	$ 2,964	$ 3,383	$ 3,156	$ 2,787	$ 2,998	$ 2,373

INCOME TAXES - Schedule of Prov

INCOME TAXES - Schedule of Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Current:
Federal	$ (12)	$ 0
State	(50)	124
Total current tax (benefit) expense	(62)	124
Deferred:
Federal	0	0
State	0	0
Total deferred tax (benefits) expense	0	0
(Benefit) Provision for income taxes	$ (62)	$ 124

INCOME TAXES - Schedule of Effe

INCOME TAXES - Schedule of Effective Tax Rate Reconciliation (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Federal income tax benefit at statutory rate	21%	21%
State income taxes, net of federal benefit	0.25%	(2.20%)
Other permanent items	(0.30%)	(0.04%)
Stock-based compensation	(9.94%)	(1.99%)
Lobbying expense	(1.95%)	(0.92%)
Research and development tax credits	(9.66%)	9.92%
Cumulative deferred adjustments	(31.39%)	26.14%
Rate change	(2.22%)	(18.06%)
Change in valuation allowance	36.20%	(36.30%)
Other	1.07%	(0.66%)
Effective income tax (benefit) expense rate	3.06%	(3.11%)

INCOME TAXES - Schedule of Defe

INCOME TAXES - Schedule of Deferred Tax Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets:
Net operating loss carryforwards	$ 5,625	$ 4,889
Payroll related accruals	256	333
Stock-based compensation	88	612
Intangible assets	90	89
Sec. 174 Capitalized costs	468	1,237
Sales tax accrual	245	197
Other	17	5
Depreciation	50	18
Research and development tax credits	708	906
Total deferred tax assets	7,547	8,286
Net deferred tax assets	7,547	8,286
Less: Valuation allowance	(7,547)	(8,286)
Deferred tax assets, net of allowance	$ 0	$ 0

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
INCOME TAXES - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 26,300
Net operating loss carryforwards, expire between 2035 and 2037	10,900
Net operating loss carryforwards, not subject to expiration	15,400
Research and development tax credits	708	$ 906
Income tax expense (credit)	(62)
Valuation allowance, decrease, Section 174 capitalized costs and stock based compensation	$ (739)

STOCKHOLDERS_ EQUITY - Narrativ

STOCKHOLDERS’ EQUITY - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
	Aug. 07, 2020	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Nov. 04, 2021
Class of Stock [Line Items]
Shares authorized (in shares)		30,000	30,000
Par value (in dollars per share)		$ 0.01	$ 0.01
Shares outstanding (in shares)		0	0
Stock-based compensation		$ 1,596	$ 2,455
Shares available for future grant (in shares)		1,138,925
Warrants, outstanding (in shares)		0
Performance Shares
Class of Stock [Line Items]
Shares issued (in shares)	265,942
Vest based on company's market price percentage	50%				100%
Outstanding (in shares)		0	177,688	228,498
Vest based on its Adjusted EBITDA percentage	50%
RSUs and Unvested Stock Options
Class of Stock [Line Items]
Unrecognized compensation cost		$ 822
Unrecognized compensation cost, weighted average expected recognition period		1 year 11 months 15 days
2015 Omnibus Incentive Plan \| Revision of Prior Period, Adjustment
Class of Stock [Line Items]
Stock-based compensation		$ (50)	$ (324)
2015 Omnibus Incentive Plan \| Maximum
Class of Stock [Line Items]
Shares authorized (up to) (in shares)		5,236,000
2015 Omnibus Incentive Plan \| Stock options
Class of Stock [Line Items]
Expiration period		10 years
2015 Omnibus Incentive Plan \| Stock options \| Maximum
Class of Stock [Line Items]
Vesting period		4 years
2015 Omnibus Incentive Plan \| Stock options \| Minimum
Class of Stock [Line Items]
Percentage of fair value per share granted (not less than)		110%
Percentage of grants owning more than voting stock		10%
Vesting period		1 year
Stock Option Plans
Class of Stock [Line Items]
Options, weighted-average fair value (in dollars per share)		$ 2.91
Series A Convertible Preferred Stock \| January 1997
Class of Stock [Line Items]
Shares authorized (in shares)		30,000
Par value (in dollars per share)		$ 0.01
Liquidation price (in dollars per share)		$ 1
Shares outstanding (in shares)		0	0

STOCKHOLDERS_ EQUITY - Schedule

STOCKHOLDERS’ EQUITY - Schedule of Equity Awards and Liability Awards Valuation Assumptions (Details)	12 Months Ended
	Dec. 31, 2023 $ / shares
Valuation assumptions:
Expected dividend yield	0%
Expected volatility, minimum	73.77%
Expected volatility, maximum	86.24%
Risk-free interest rate, minimum	4.19%
Risk-free interest rate, maximum	4.65%
Liability Awards
Valuation assumptions:
Exercise price (in dollars per share)	$ 2.68
Expected dividend yield	0%
Expected volatility, minimum	79.88%
Expected volatility, maximum	82.02%
Risk-free interest rate, minimum	4.80%
Risk-free interest rate, maximum	5.59%
Minimum
Valuation assumptions:
Grant price (in dollars per share)	$ 2.44
Exercise price (in dollars per share)	$ 2.44
Expected life (in years)	2 years 6 months
Minimum \| Liability Awards
Valuation assumptions:
Expected life (in years)	29 days
Maximum
Valuation assumptions:
Grant price (in dollars per share)	$ 3.78
Exercise price (in dollars per share)	$ 3.78
Expected life (in years)	3 years 9 months
Maximum \| Liability Awards
Valuation assumptions:
Expected life (in years)	6 months 14 days

STOCKHOLDERS' EQUITY - Schedule

STOCKHOLDERS' EQUITY - Schedule of Stock Option Activity (Details) - Stock Option Plans - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Number of Shares Subject to Issuance
Outstanding, beginning balance (in shares)	1,120,244	496,424
Granted (in shares)	627,507	732,228
Forfeited (in shares)	(595,037)	(108,408)
Exercised (in shares)	0
Outstanding, ending balance (in shares)	1,152,714	1,120,244	496,424
Exercisable at end of period (in shares)	550,964
Weighted- average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 3.68	$ 6.13
Granted (in dollars per share)	2.91	2.14
Forfeited (in dollars per share)	4.05	4.53
Exercised (in dollars per share)	0
Outstanding, ending balance (in dollars per share)	3.07	$ 3.68	$ 6.13
Exercisable at end of period (in dollars per share)	$ 3.47
Weighted- average Remaining Contractual Term
Outstanding	3 years 2 months 4 days	3 years 6 months	3 years 10 days
Exercisable at end of period	2 years 3 months 29 days
Aggregate Intrinsic Value
Outstanding	$ 38	$ 84	$ 528
Exercisable at end of period	$ 23

STOCKHOLDERS_ EQUITY - Summary

STOCKHOLDERS’ EQUITY - Summary of Stock Options (Details)	12 Months Ended
STOCKHOLDERS’ EQUITY - Summary of Stock Options (Details)	Dec. 31, 2023 $ / shares shares
Options Outstanding
Number of Options (in shares) \| shares	1,152,714
Weighted- average Remaining Life	3 years 2 months 4 days
Weighted-average Exercise Price (in dollars per share)	$ 3.07
Options Exercisable
Number of Options (in shares) \| shares	550,964
Weighted-average Exercise Price (in dollars per share)	$ 3.47
Exercise Price One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	1.71
Range of Exercise Prices, Maximum (in dollars per share)	$ 3.69
Options Outstanding
Number of Options (in shares) \| shares	1,024,398
Weighted- average Remaining Life	3 years 11 months 12 days
Weighted-average Exercise Price (in dollars per share)	$ 2.47
Options Exercisable
Number of Options (in shares) \| shares	484,081
Weighted-average Exercise Price (in dollars per share)	$ 2.35
Exercise Price Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	3.78
Range of Exercise Prices, Maximum (in dollars per share)	$ 11.50
Options Outstanding
Number of Options (in shares) \| shares	128,316
Weighted- average Remaining Life	2 years 10 months 6 days
Weighted-average Exercise Price (in dollars per share)	$ 8
Options Exercisable
Number of Options (in shares) \| shares	66,883
Weighted-average Exercise Price (in dollars per share)	$ 11.50

STOCKHOLDERS' EQUITY - Schedu_2

STOCKHOLDERS' EQUITY - Schedule of Restricted Stock Unit (RSU) and Performance Stock Unit (PSU) Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Restricted Stock Units
Number of Shares
Outstanding, beginning balance (in shares)	214,892	408,376
Granted (in shares)	249,412	139,958
Forfeited (in shares)	(70,959)	(36,445)
Vested and Settled in shares (in shares)	(332,845)	(296,997)
Outstanding, ending balance (in shares)	60,500	214,892
Weighted Average Grant Date Fair Value
Outstanding, beginning of period (in dollars per share)	$ 8.43	$ 10.43
Granted (in dollars per share)	2.34	2.23
Forfeited (in dollars per share)	10.04	10.35
Vested and Settled in shares (in dollars per share)	4.29	8.03
Outstanding, end of period (in dollars per share)	$ 4.23	$ 8.43
Performance Stock Units
Number of Shares
Outstanding, beginning balance (in shares)	177,688	228,498
Forfeited (in shares)	(88,844)	(50,810)
Vested and Settled in shares (in shares)	(88,844)
Outstanding, ending balance (in shares)	0	177,688
Weighted Average Grant Date Fair Value
Outstanding, beginning of period (in dollars per share)	$ 7.91	$ 7.91
Forfeited (in dollars per share)	7.91	7.91
Vested and Settled in shares (in dollars per share)	7.91
Outstanding, end of period (in dollars per share)	$ 0	$ 7.91

STOCKHOLDERS_ EQUITY - Schedu_2

STOCKHOLDERS’ EQUITY - Schedule of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Equity [Abstract]
Stock options	$ 666	$ 382
Restricted stock units	930	1,342
Performance stock units	0	731
Stock-based compensation expense, total	$ 1,596	$ 2,455

STOCKHOLDERS_ EQUITY - Schedu_3

STOCKHOLDERS’ EQUITY - Schedule of Stock-based Compensation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share based compensation	$ 1,596	$ 2,455
Selling, general and administrative
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share based compensation	1,358	1,789
Research and development
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share based compensation	$ 238	$ 666

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	12 Months Ended
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Product Liability Contingency [Line Items]
Rent expense	$ 68,000	$ 78,000
Operating lease, right of use asset	0
Operating lease, liability	0
Bonus liability	3,245,000	3,156,000	$ 3,414,000	$ 2,964,000	$ 3,383,000	$ 2,787,000	$ 2,998,000	$ 2,373,000
2020 Bonus Plan
Product Liability Contingency [Line Items]
Bonus liability	$ 824,000	$ 846,000

RETIREMENT PLAN (Details)

RETIREMENT PLAN (Details) - Retirement Savings 401k Plan - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Maximum annual contributions	35%
Employer matching contribution, percent of match	50%
Employer matching contribution, percent of employees' gross pay	6%
Matching contributions	$ 108	$ 118

REVISION OF PRIOR PERIOD FINA_3

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Financial Statements and Footnotes as Adjusted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended							6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
BALANCE SHEET
Accrued expenses	$ 3,414	$ 2,964	$ 3,383	$ 2,787	$ 2,998	$ 2,373		$ 2,964	$ 2,998	$ 3,414	$ 2,787	$ 3,245	$ 3,156
Accumulated deficit	(134,549)	(133,825)	(132,972)	(130,938)	(130,140)	(128,970)		(133,825)	(130,140)	(134,549)	(130,938)	(133,565)	(131,585)	$ (127,426)
Total stockholders’ equity	16,007	16,353	16,922	17,581	17,683	18,333		16,353	17,683	16,007	17,581	17,276	17,667	19,048
STATEMENT OF OPERATIONS
Selling, general and administrative	3,677	3,937	3,995	2,991	3,196	3,019		7,931	6,216	11,609	9,207	15,127	12,707
Total operating expenses	5,227	5,213	5,303	4,452	4,814	4,623		10,515	9,437	15,743	13,889	19,807	18,721
Loss from operations	(895)	(849)	(1,381)	(798)	(1,170)	(1,544)		(2,229)	(2,714)	(3,125)	(3,512)	(2,276)	(4,030)
Net loss	$ (724)	$ (853)	$ (1,387)	$ (798)	$ (1,170)	$ (1,544)	$ (8,007)	$ (2,240)	$ (2,714)	$ (2,964)	$ (3,512)	$ (1,980)	$ (4,159)
Loss per common share
Basic (in dollars per share)	$ (0.04)	$ (0.04)	$ (0.07)	$ (0.04)	$ (0.06)	$ (0.08)		$ (0.12)	$ (0.14)	$ (0.15)	$ (0.19)	$ (0.10)	$ (0.22)
Diluted (in dollars per share)	$ (0.04)	$ (0.04)	$ (0.07)	$ (0.04)	$ (0.06)	$ (0.08)		$ (0.12)	$ (0.14)	$ (0.15)	$ (0.19)	$ (0.10)	$ (0.22)
STATEMENT OF STOCKHOLDERS’ EQUITY
Net loss	$ (724)	$ (853)	$ (1,387)	$ (798)	$ (1,170)	$ (1,544)	(8,007)	$ (2,240)	$ (2,714)	$ (2,964)	$ (3,512)	$ (1,980)	$ (4,159)
Accumulated deficit	(134,549)	(133,825)	(132,972)	(130,938)	(130,140)	(128,970)		(133,825)	(130,140)	(134,549)	(130,938)	(133,565)	(131,585)	(127,426)
Total Stockholders’ Equity	16,007	16,353	16,922	17,581	17,683	18,333		16,353	17,683	16,007	17,581	17,276	17,667	19,048
STATEMENT OF CASH FLOWS
Net loss	(724)	(853)	(1,387)	(798)	(1,170)	(1,544)	(8,007)	(2,240)	(2,714)	(2,964)	(3,512)	(1,980)	(4,159)
Increase (decrease) in accounts payable and accrued expenses			783			(1,073)		125	(349)	431	(366)	$ 616	(260)
As Previously Reported
BALANCE SHEET
Accrued expenses	2,350	1,980	2,475	2,036	2,321	1,768		1,980	2,321	2,350	2,036		2,319
Accumulated deficit	(133,485)	(132,841)	(132,064)	(130,187)	(129,463)	(128,365)		(132,841)	(129,463)	(133,485)	(130,187)		(130,748)	(126,897)
Total stockholders’ equity	17,071	17,337	17,830	18,332	18,360	18,938		17,337	18,360	17,071	18,332		18,504	19,577
STATEMENT OF OPERATIONS
Selling, general and administrative	3,597	3,861	3,924	2,917	3,124	2,943		7,784	6,068	11,382	8,985		12,399
Total operating expenses	5,147	5,137	5,232	4,378	4,742	4,547		10,368	9,289	15,516	13,667		18,413
Loss from operations	(815)	(773)	(1,310)	(724)	(1,098)	(1,468)		(2,082)	(2,566)	(2,898)	(3,290)		(3,722)
Net loss	$ (644)	$ (777)	$ (1,316)	$ (724)	$ (1,098)	$ (1,468)	(7,478)	$ (2,093)	$ (2,566)	$ (2,737)	$ (3,290)		$ (3,851)
Loss per common share
Basic (in dollars per share)	$ (0.03)	$ (0.04)	$ (0.07)	$ (0.04)	$ (0.06)	$ (0.08)		$ (0.11)	$ (0.14)	$ (0.14)	$ (0.17)		$ (0.20)
Diluted (in dollars per share)	$ (0.03)	$ (0.04)	$ (0.07)	$ (0.04)	$ (0.06)	$ (0.08)		$ (0.11)	$ (0.14)	$ (0.14)	$ (0.17)		$ (0.20)
STATEMENT OF STOCKHOLDERS’ EQUITY
Net loss	$ (644)	$ (777)	$ (1,316)	$ (724)	$ (1,098)	$ (1,468)	(7,478)	$ (2,093)	$ (2,566)	$ (2,737)	$ (3,290)		$ (3,851)
Accumulated deficit	(133,485)	(132,841)	(132,064)	(130,187)	(129,463)	(128,365)		(132,841)	(129,463)	(133,485)	(130,187)		(130,748)	(126,897)
Total Stockholders’ Equity	17,071	17,337	17,830	18,332	18,360	18,938		17,337	18,360	17,071	18,332		18,504	19,577
STATEMENT OF CASH FLOWS
Net loss	(644)	(777)	(1,316)	(724)	(1,098)	(1,468)	(7,478)	(2,093)	(2,566)	(2,737)	(3,290)		(3,851)
Increase (decrease) in accounts payable and accrued expenses			712			(1,149)		(22)	(497)	204	(588)		(568)
Adjustment
BALANCE SHEET
Accrued expenses	1,064	984	908	751	677	605		984	677	1,064	751		837
Accumulated deficit	(1,064)	(984)	(908)	(751)	(677)	(605)		(984)	(677)	(1,064)	(751)		(837)	(529)
Total stockholders’ equity	(1,064)	(984)	(908)	(751)	(677)	(605)		(984)	(677)	(1,064)	(751)		(837)	(529)
STATEMENT OF OPERATIONS
Selling, general and administrative	80	76	71	74	72	76		147	148	227	222		308
Total operating expenses	80	76	71	74	72	76		147	148	227	222		308
Loss from operations	(80)	(76)	(71)	(74)	(72)	(76)		(147)	(148)	(227)	(222)		(308)
Net loss	$ (80)	$ (76)	$ (71)	$ (74)	$ (72)	$ (76)	(529)	$ (147)	$ (148)	$ (227)	$ (222)		$ (308)
Loss per common share
Basic (in dollars per share)	$ (0.01)	$ 0	$ 0	$ 0	$ 0	$ 0		$ (0.01)	$ 0	$ (0.01)	$ (0.02)		$ (0.02)
Diluted (in dollars per share)	$ (0.01)	$ 0	$ 0	$ 0	$ 0	$ 0		$ (0.01)	$ 0	$ (0.01)	$ (0.02)		$ (0.02)
STATEMENT OF STOCKHOLDERS’ EQUITY
Net loss	$ (80)	$ (76)	$ (71)	$ (74)	$ (72)	$ (76)	(529)	$ (147)	$ (148)	$ (227)	$ (222)		$ (308)
Accumulated deficit	(1,064)	(984)	(908)	(751)	(677)	(605)		(984)	(677)	(1,064)	(751)		(837)	(529)
Total Stockholders’ Equity	(1,064)	(984)	(908)	(751)	(677)	(605)		(984)	(677)	(1,064)	(751)		(837)	$ (529)
STATEMENT OF CASH FLOWS
Net loss	$ (80)	$ (76)	(71)	$ (74)	$ (72)	(76)	$ (529)	(147)	(148)	(227)	(222)		(308)
Increase (decrease) in accounts payable and accrued expenses			$ 71			$ 76		$ 147	$ 148	$ 227	$ 222		$ 308